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ABSTRACT 
In May 2007, the United States' President promised to contribute an additional US$ 
30 million to the fight against HIV/AIDS. This is only one of the most recent donor 
commitment of what has been a substantial amount of foreign aid to fight HIV/AIDS 
(UNAIDS estimates that donor governments committed US$5.6 billion in 2006 
alone). Compared to other regions in the world, Sub-Saharan Africa is the most 
heavily affected by HIV and AIDS with an estimated 24.7 million people living with 
HIV. Due to its high levels of infection, many African states receive substantial 
amounts of foreign aid specific to HIV/AIDS. However, it is unclear whether foreign 
aid actually helps to curb the epidemic or if it increases treatment for people living 
with HIV. In order to sustain this funding, donors need evidence that foreign aid is 
having a positive impact on the HIV I AIDS epidemic. 
In an attempt to find whether such evidence indeed does exist, I investigate the 
relationship between HIV I AIDS related foreign aid and two indicators of the AIDS 
epidemic: (1) HIV reduction and (2) access to antiretroviral therapy (ART) treatment. 
In doing so, I also consider the influence of four national characteristics that may 
relate both to foreign aid and to HIV prevention and ART coverage and thus obscure 
the impact of foreign aid. The national characteristics for this study include: state 
capacity, governance, the type of AIDS response, and the severity of the epidemic. 
I collect a wealth of data on 29 Sub-Saharan African countries from vanous 
international institutions. The study is transparent and can be replicated, adjusted and 
expanded for future research. The empirical results indicate that HIV I AIDS related 
foreign aid increases national ART coverage. It also suggests that national 
characteristics do not appear to alter the impact of AIDS funding on treatment. The 
research yields a second major finding: there is no association between foreign aid 
and HIV prevalence reduction. This result suggests that foreign aid really may not be 
a very effective component to reducing HIV prevalence; yet it is more likely a 
reflection of the difficulties in measuring HIV reduction, poor data quality and the 
difficulties in controlling for a multitude of indicators which may shape HIV 
reduction. 
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CHAPTER ONE 
INTRODUCTION 
To maintain the AIDS response as a priority we need to show continual results 
on the ground - ie, that the major investments made in fighting AIDS are having 
a commensurate effect in terms of averted infections, illness, and deaths. 
1.1 The Problem 
- Peter Piot, Executive Director of the Joint United 
Nations Programme on HIV/AIDS [UNAIDS]' 
Sub-Saharan Africa is home to almost two-thirds of the global HIV I AIDS population 
amounting to 24.7 million people (UNAIDS, 2006).2 The epidemic presents a range of 
threats to the region from undermining economic growth, to challenging security and 
reversing development gains. This has resulted in strong domestic and international 
calls for control and management of the disease.3 
Since the onset of the epidemic in Sub-Saharan Africa, countries have responded to 
the HIV I AIDS crisis in many ways. African governments and non-state actors such as 
nongovernmental organizations (NGOs), community based organizations and civil 
society organizations manage, control and combat HIV I AIDS through a variety of 
tools ranging from legislation, to education, to public health campaigns, and to 
providing health services (Poku, 2006). But because Sub-Saharan Africa is also the 
poorest region in the world, many countries are unable to combat their epidemics with 
domestic resource alone. Donor aid is needed to provide AIDS-related services, 
programmes and campaigns aimed at disease reduction and management, such as 
treating and caring for people living with HIV I AIDS. 
I This quote is taken from Piot (2006, p. 527). 
2 HIV (Human Immunodeficiency Virus)!AIDS (Acquired Immune Deficiency Syndrome) 
3 For more information about the threat AIDS poses to the region, see World Bank, International 
Monetary Fund (IMF), & NetLibrary, Inc (2005). 
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The international community has responded to the devastating impact of HIV I AIDS 
through international agreements and financial commitments.4 For example, the 
United Nations' (UN) Millennium Development Goals (MDGs) of 2000 committed 
the world to halting and reversing the spread of HIV/AIDS by 2015. But the 
international community has made its greatest contribution to fighting HIV I AIDS 
through foreign aid. Donor resources for AIDS have increased drastically over the 
past decade and currently finance about 80 percent of HIV I AIDS programmes in Sub-
Saharan Africa (de Waal, 2006).5 The international community has also created 
institutions to assist in the financing, implementation, and organization of donor funds 
for HIV/AIDS, such as the World Bank's Multi-country HIV/AIDS Programme 
(MAP), Global Fund to Fight AIDS, Tuberculosis and Malaria (GF ATM) and the 
United States' President's Emergency Plan for AIDS Relief (PEPFAR). 
But while large amounts of HIV I AIDS related foreign assistance have been directed 
to Sub-Saharan Africa for some time now, few studies have examined its 
effectiveness. While we know that aid is allocated for prevention and treatment 
programmes, no research has, of yet, established the degree to which this aid 
translates into effective prevention or treatment. We also know very little about the 
influence of the recipient state on the effectiveness of HIV I AIDS related aid. Piot's 
recent argument that we need to demonstrate such results is a clear reflection of this 
gap in our knowledge. 
In this thesis I will address two questions: (1) Is there a demonstrable link between 
HIV/AIDS related foreign assistance (HARFA)6 and the progress made in the fight 
against HIV I AIDS in Sub-Saharan Africa, and (2) do other factors modify this 
potential association? 
I will consider two indicators of national progress in responding to HIV I AIDS: HIV 
prevention and HIV treatment. The two indicators are both valid measures of a 
country's success in responding to HIV/AIDS; however they differ significantly in 
4 HIV/AIDS is listed as one of most important issues of United States' foreign policy in Africa along 
with terrorism, energy and competition with China and other countries (Lake, Whitman, Lyman, & 
Morrison, 2006). This prioritization raises awareness about the issue both globally and within the US. 
5 Donor resources for AIDS in Africa rose tenfold from 1996 to 2005 (de Waal, 2006). 
6 The term HARF A will be used throughout this paper to condense the text. 
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character. The prevention indicator is 'epidemiological' in that it refers to the change 
in the number of individuals who are estimated to be infected with the HIV virus; 
whereas, the treatment indicator is more 'political' or even 'bureaucratic' in that it 
refers to the extent to which governments (and other stakeholders) are able to provide 
a supply of antiretroviral medication that meets the demand. The importance of this 
distinction will be discussed further below; briefly however it relates to the 
complexity of the causal model used in this study. In this thesis, I will refer to the 
dependent variable as 'HIV I AIDS progress'. It is a variable with two separate 
empirical indicators: (1) HIV prevention will be measured by the rate of change in 
HIV prevalence,7 and (2) HIV treatment will be measured by antiretroviral therapy 
(ART) coverage. 
As we shall see further below, scholars argue that several factors influence the 
effectiveness of the response and may influence the efficiency with which HARF A 
may result in HIV prevention and treatment. The complexity of accounting for the 
potential effects of all possible factors would be immense and clearly beyond the 
reasonable scope of this research. For the purpose of this thesis I have therefore 
limited the inclusion of four factors that are particularly relevant and most frequently 
cited by the literature: state capacity, national governance, national AIDS 
governance, and the severity of the epidemic. 
1.2 Significance of study 
There are three general conclusions that I could reach: (1) there is no association 
between HARF A and HIV I AIDS improvement; (2) HARF A is the universal solvent 
for combating HIV/AIDS; or (3) the association of HARFA and HIV/AIDS depends 
on the characteristics of the recipient country. Which conclusion is best supported by 
the evidence will have important implications for how countries and multilateral 
institutions should best allocate HIV I AIDS related funding. 
The level of HIV I AIDS funding has risen significantly over the past decade due to 
global awareness and concern over the epidemic. UNAIDS reports that HIV/AIDS 
7 HIV prevalence indicates the percentage of people in a population who are living with HIV. The 
change rate of HI V prevalence measures the speed of HI V prevalence growth or decline. 
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resources rose from approximately US$ 300 million in 1996 to US$ 6.1 billion in 
2004 (UNAIDS, 2004a). In response to the expansion of AIDS funding, global 
institutions and donor countries developed aid agencies specific to HARF A. The 
World Bank launched MAP in 2000 providing loans to national AIDS commissions. 
In 2001, the international community engaged in discussions on the epidemic at the 
UN General Assembly Special Session on HIV/AIDS (UNGASS) resulting in the 
establishment of GFATM. Growing domestic concern in the United States resulted in 
the development of PEPF AR, which was announced in 2003 as a bilateral aid 
programme for 15 focus countries (13 of which are in Africa). 
Since these three major aid programmes disburse funds separately, they monitor their 
own resources individually and have different bases for evaluating the effectiveness of 
their efforts. 8 For example, the World Bank identifies how much money is committed 
and disbursed; which organizations receive funding; how the money is spent (i.e. 
number of people trained in HIV I AIDS); and what the outcomes of the funding are 
(i.e. the number of condoms disbursed, number of testing sites, number of people on 
antiretroviral therapy) (Gorgens-Albino, Mohammad, Blankhart, & Odutolu, 2007). 
Similarly, PEPFAR created their own target goals referred to as "2-7-10": provide 
treatment for two million people living with HIV I AIDS, prevent seven million new 
infections, and provide care for ten million people infected with and affected by 
HIV I AIDS by 2008 (A. Patterson, 2006). Annual congressional reports provide 
updates on PEPF AR' s progress towards meeting these targets in order to secure future 
funding. 9 
GF ATM differs slightly from the previous two funding agencies. Rather than setting 
general targeted goals, they distribute grants based on proposal applications to 
government agencies and local NGOs. Each proposed programme has specified 
targets in which GF A TM monitors and evaluates after 2 years to help decide whether 
to continue funding the programme (Radelet & Siddiqi, 2007). 
8 See A. Patterson (2006) for a complete comparison ofPEPF AR and GFATM. 
9 For more information specific to PEPFAR, see Otterman (2003). 
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These three funding agencies appear to work on the assumption that more financial 
aid directed at HIV / AIDS will help to combat the epidemic. In their own monitoring 
and evaluation studies, these aid agencies evaluate their programmes activities rather 
than the effect of the programme on the epidemic. Yet, there is no agreed mechanism 
among these agencies on how best to evaluate the affect of HIV / AIDS related 
funding. While there are independent studies that objectively track and analyze the 
total amount international donors give to HIV / AIDS (Kates & Lief, 2006), there is no 
research that empirically tests the effectiveness of overall HIV / AIDS related funding 
in terms of actual prevention or treatment. 
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CHAPTER TWO 
LITERATURE REVIEW 
The political science literature on HIV I AIDS can be divided into two main categories: 
HIV I AIDS impact studies and national HIV I AIDS policy studies. Impact studies are 
crucial to understand the effects and consequences of the epidemic on societies, 
economies and politics; I 0 whereas the policy studies assess how governments (both 
donors and recipient countries) respond to the epidemic and why national responses 
differ. II The research agenda for this study represents an alternative category because 
it combines political science with economics and epidemiology. 
The political science and economic literature on foreign aid effectiveness neglects to 
analyze HARF A specifically. HIV I AIDS is often addressed as one of the eight 
Millennium Development Goals (MDGs)12 and much of the literature on the MDGs 
assumes, without empirical support, that more foreign aid will reduce or reverse the 
growth of HIV prevalence and increase ART access. The existing literature on 
national characteristics that affect HIV/AIDS is also surprisingly limited, and often 
remains untested. 
This study intends to establish a link between foreign aid and HIV I AIDS progress, 
which can then be empirically tested. The following literature review will identify 
relevant studies and theories with which we can formulate new research questions and 
develop methodology for this study. I divide the literature into two sections: aid 
effectiveness and national characteristics that affect HARF A and HIV I AIDS. 
10 The literature on the impact ofHIY/AIDS is extensive. For some examples, look to Barnett and 
Whiteside (2006), Boone and Batsell (2001), Mattes (2003), Mattes and Manning (2004), Nattrass 
(2004), Strand, Matlosa, Strode, and Chirambo (2005). 
11 For a literature review on how and why states respond differently to the HIY/AIDS epidemic (i.e. 
governance problems, donor dependency versus state domination, and past experience with public 
health threats) see Strand (2007) and Baldwin (2005). Also, Lieberman (2005) analyses the impact of 
politically salient ethnicity on national responses to HIY/AIDS. 
12 The MDGs are to eradicate extreme poverty and hunger; to achieve universal primary education; to 
promote gender equality and empower women; to reduce child mortality; to improve maternal health; 
to combat HIY / AIDS, malaria and other disease; to ensure environmental sustainability; and to develop 
a global partnership for development. 
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2.1 Aid effectiveness 
A multitude of studies explore the impact of aid on a range of topics such as: 
economic growth,13 democracy,14 quality of life, 15 the expansion of government,16 the 
environment,17 gender equality, 18 and poverty reduction (which often combines topics 
such as education and health).19 Absent from this literature is research relating to the 
impact of donor assistance on HIV / AIDS. Yet even among the existing literature, 
academically based knowledge about the effectiveness of foreign aid in general IS 
assorted, contested and extensive. 
Yet the literature on general aid effectiveness does provide a basis for understanding 
the impact of foreign aid on HIV / AIDS. The early foreign aid literature argues that the 
rationale was to fill the resource gaps in a developing county's macro-economy. 
"Effective use of aid was designed to bridge the savings/investment gap and the 
balance of payments gap in the developing countries and put them on the path to self-
sustaining development (Sobhan, 2002, p. 540). As levels of aid increased over time, 
the literature expanded to address conditionality as well as the roles and limitations of 
multilateral development agencies such as the World Bank and the IMF.2o Regardless 
of the institutionalization of foreign aid, Sobhan argues that foreign aid primarily 
became sustained through the humanitarian concerns of average taxpayers in donor 
countries. The recent efforts by Jeffrey Sachs and celebrities such as Bono have 
appealed to these average citizens to fill the resource gaps for poverty reduction. 
Sachs believes the poverty trap will prevent many countries from achieving the 
MDGs, which includes a goal focused on HIV / AIDS reduction (2005b). He argues 
that "development assistance can close this (poverty trap) financing gap" (Sachs, 
2005b, p. 5). 
13 Specific studies include Burnside and Dollar (2000), Burnside and Dollar (2004), Hansen and Tarp 
(2000), and Easterly (2003). Other studies are cited in Radelet, Clemens, and Bhavnani (2004) and 
Tarp (2000). 
14 See Finke, Lifian, and Seligson (2006). Also see Djankov, Montalvo, and Reynal-Querol (2006) for 
further literature. 
15 See Kosack (2003). 
16 See Remmer (2004). 
17 For review of the existing literature see Tarp (2000). 
18 For review of the existing literature see Tarp (2000). 
19 For review of the existing literature see Tarp (2000). 
20 For more background on foreign aid literature, see Radelet et al. (2004). 
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Sachs and others convinced the international community that increasing foreign aid 
will lead to the achievement of the MDGs.21 With a flood of new money going to 
developing countries there is an ongoing analytical and policy debate on aid 
effectiveness.22 For example, Garrett (2007) identifies challenges specific to foreign 
aid directed at global health. She argues that health targets are too specific; aid gets 
trapped in bureaucracies and multilateral banks; corruptions is rampant; donor 
agencies lack coordination; the conditionality of aid prevents homegrown policies and 
priorities; stove piping is common and does not provide a holistic approach to health 
because aid is given to specific programs or disease, which limits other basic health 
care services. Farmer (2007, para. 4) agrees that "the influx of AIDS funding can 
indeed strangle primary care, distort public health budgets, and contribute to brain 
drain," however he argues that this only happens with poorly designed programs. 
Garrett and Farmer demonstrate that when we move from the literature on foreign aid 
for development to the literature specific to foreign aid for HIV I AIDS, the debates 
and core issues remain similar. 
Yet much of the literature specific to foreign aid for HIV I AIDS tracks donor 
commitments and spending or projects how much money is needed to assist 
developing countries in their fight against AIDS. The more critical assessments 
address specific donor programmes. For example A. Patterson (2006) claims that 
PEPF AR money primarily goes to multinational NGOs, US academic institutions and 
brand-name medicine?3 Other scholars critique the primary recipient organizations,24 
the slow distribution or cutting of funds,25 and aid conditionalitl6 of PEPF AR. In 
regard to GF ATM and MAP, both agencies are in a transition period and under new 
leadership (Garrett, 2007). Academics also acknowledge problems with domestic 
prioritization of HIV/AIDS funding (de Waal, 2003). For example, governments are 
the primary recipients of GF A TM grants and yet there is no evidence to suggest that 
increasing HARF A influences change in their domestic policy (A. Patterson, 2006). 
21 For criticism of Sachs' initiative for foreign aid see Easterly (2006). 
22 For an expanded discussion of this debate, see Ehrenpreis (2007). 
23 For example, US goods and contractors receive 70 percent of PEPF AR funding for Nigeria (A. 
Patterson, 2006, p. 163). 
24 Almost a quarter of US funding for HIY / AIDS is channeled through faith-based organizations that do 
not promote condom use (Nelson, 2006). 
25 See Sachs (2005b) and Nelson (2006). 
26 20 percent of PEPF AR funding is allocated for prevention however 1/3 of this must go to abstinence 
only education ("HIY prevention policy," 2006). 
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Despite criticisms about HARF A, most scholars, including the critics, recognize that 
foreign aid needs to increase in quality and quantity for the achievement of the MDGs 
("How to promote global health", 2000; A. Patterson, 2007; Poku, 2006). 
An influential study by Burnside and Dollar (2000; 2004) provides a model for 
measuring aid effectiveness.27 These scholars present interesting and influential 
results regarding the impact of foreign aid on economic growth (or average annual 
growth rate of real per capita GOP). Through a comprehensive study, they determine 
that aid is more effective in countries with good policy management whereby 
countries experience 1 percent poverty reduction with 1 percent of GOP in assistance 
(World Bank, 1998, p. 14)?8 Their discovery of a link between foreign aid and good 
governance provides evidence that other national characteristics can moderate aid 
effecti veness. 
The results from the Burnside and Dollar study altered international foreign aid policy 
and potentially shaped US AIDS foreign aid policy (Burnside & Dollar, 2004). In 
response to the study, the United States (US) established the Millennium Challenge 
Account (MCA) to improve aid effectiveness by giving a significant amount of 
official development assistance (ODA) to countries which rule justly (based on World 
Bank indicators and Freedom House scores), invest in their people, and have 
economic freedom (World Bank and IMF indicators) (Kauffman & Kraay, 2002). In 
relation to US AIDS foreign aid policy, the Burnside and Dollar study may have 
influenced the selection of the PEPF AR focus countries. One attribute of PEPF AR is 
that it focuses on fifteen countries whereby these countries receive significantly more 
attention and bilateral aid for AIDS from the US. While it is unclear how the US 
government choose the fifteen PEPF AR focus countries, one can postulate that the 
their selection was influenced by the ideology of the MCA. Radelet (2003) identifies 
that countries with comparably high HIV prevalence such as Lesotho, Malawi and 
Swaziland were not selected however these same countries have lower MCA mark, 
which may be the cause of their exclusion.29 
27 These articles superceded a World Bank report published in 1998 by the same authors. 
28 For a discussion on the methodological problems of this study please refer to Sobhan (2002), Radelet 
et al. (2004), and Hansen and Tarp (2000). 
29 A. Patterson identifies three criteria that led to the selection of the fifteen PEPFAR focus countries: 
(I) a country had to be engaged on the AIDS issue and interested in meeting targets; (2) a country had 
to have a large number of HlV-positive people; and (3) a country needed to have US agencies (mainly 
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There are far fewer assessments of HARF A in the aid effectiveness literature. De 
Waal claims that "there is a tendency for HIV/AIDS to become an add-on to other 
'more urgent' demands" (2003, p. 22). The issue of HIV/AIDS in Africa appears to 
have been thrown into the complex development pile, making it one of many issues 
that donors must address. 
Thus, there is a major gap in our knowledge about the effectiveness of aid directed at 
HIV I AIDS prevention, treatment, and care programs. The literature that does exist on 
foreign aid for HIV I AIDS is mostly commentary on the inefficiencies of aid agencies 
opposed to quantitative assessments of aid effectiveness. We also discover some good 
reasons to examine intervening factors that may impact on aid effectiveness because 
recent studies have identified moderating variables, such as institutions and policy, 
which influence the effectiveness of foreign aid. As a result, donors have shifted 
foreign aid generally to countries with good governance. 
2.2 National characteristics that affect HARFA and HIV/AIDS 
Social scientists researching and writing on HIV I AIDS have identified four national 
characteristics that may influence the epidemic: state capacity, governance, AIDS 
governance and the severity of the epidemic. This is not to say that there are not other 
factors both biomedical and non-biomedical, such as poverty, gender inequality, 
culture, religion and social capital, which also shape HIV I AIDS progress;30 but rather 
that I will focus only on these four influential factors. 
De Waal portrays the bleak reality of HIV I AIDS in Africa by stating that "centralized, 
state-imposed programmes of HIV I AIDS control in Africa" do not exist due to limited 
state capacity (2003, p.18). In an attempt to explain why some countries have 
effectively addressed the epidemic while others have failed, Price-Smith, Tauber, and 
Bhat (2004) empirically examine the impact of state capacity on the reduction of HIV 
incidence.3l They posit that in countries with greater levels of state capacity, AIDS 
the Centers for Disease Control and Prevention and United States Agency for International 
Development [USAID]) already working in the country (2006, pp. 141-142). 
30 Kennedy identifies a strong relationship between religiosity and HIV diffusion in South Africa 
(2006). Please see her work for further citations on non-biomedical factors affecting HIV diffusion. 
31 HIV incidence refers to the yearly infection rate. 
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programs are easier to implement and hence have more effective responses to the 
epidemic; whereas, countries with low state capacity are in a cycle of poverty and 
decline and cannot adopt effective AIDS responses. Using a random sample of 50 
countries, they find a strong correlation between state capacity and change in HIV 
incidence. Yet they recognize that it is not the only variable that determines reduction 
in HIV levels. 
Poku (2006) also identifies state capacity as a potential hindrance to HIV I AIDS 
progress. He argues that foreign aid cannot be absorbed effectively in many low 
income countries due to limited capacity. "If left unrectified, this incapacity to absorb 
funds is most likely to lead donors to reduce their financial commitments, which 
would jeopardize the long-term sustainability to the AIDS response" (Poku, 2006, p. 
355). Poku recognizes that donors and African countries must increase sustained 
health service delivery. He also indicates that foreign aid and HIV I AIDS interventions 
work best in conjunction with good governance practices, another state characteristic. 
D. Patterson (2001) makes a case that good governance produces more effective 
national AIDS programs. Using the arguments of Amartya Sen and Joseph Stiglitz, he 
posits that governance indicators are good guides to the potential effectiveness of 
AIDS programs. "A focus on improved governance provides concrete and measurable 
programming options to increase government effectiveness in the response to AIDS, 
which may also increase visible government commitment as well" (D. Patterson, 
2001, p. 42). Hsu (2004,2005) argues that good governance and development slows 
and reduces HIV prevalence through a human rights agenda as well as transparency 
between government agencies and civil society. Baldwin (2005) postulates that "if 
education and persuasion are to be central to prevention, a free, independent, and 
trustworthy mass media are required" (ibid: 288). In a study on the advantages of 
democracy for development, Halperin, Siegles and Weinsteion point out that "the 
openness encouraged under democratic governments is a distinct advantage for public 
health efforts" (2005, p. 42). Even though the Halperin et al. study is not solely 
focused on Africa, they empirically show that democracies have lower HIV 
prevalence than autocracies. Many scholars advocate that good governance practices, 
or more democratic governance, improve the effectiveness of the response to the 
HIV I AIDS epidemic. 
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Separate from governance, some scholars have identified AIDS governance as a third 
national characteristic that may affect HIV I AIDS reduction and treatment. AIDS 
governance refers to how governments respond to the HIV I AIDS epidemic 
specifically. For instance, Hsu (2005) identities specific governance practices for 
HIV/AIDS control necessary for an effective AIDS response.32 Strand (2007) 
provides the most comprehensive and testable hypothesis on the impact of AIDS 
governance. He suggests that this concept should be considered an independent 
variable that describes the type of response to the epidemic. He identifies three types 
of governmental responses to HIV/AIDS: idealistic, authoritative, and authoritarian 
and asserts that the first two occur under democratic regimes. Where an idealist 
response seeks to maximize aspects such as participation, accountability and human 
rights, the authoritative response would consider reducing those rights if that would 
generate a more effective response.33 Strand's argument suggests that the type of 
AIDS response, or AIDS governance, may influence HIV I AIDS progress. 
The type of epidemic itself is a final element that might influence HIV I AIDS 
progress. Barnett and Whiteside (2006) argue that social, economic and cultural 
factors explain the level and flows of the HIV I AIDS epidemic. They identify four 
types of flows and levels of the epidemic experienced by different societies: (1) low 
and static, (2) slow-moving, (3) slow-moving that will gain momentum sustaining 
high levels of infection, and (4) rapid increase with highest overall levels of infection. 
Through an analysis of why the epidemic happens, they consider social cohesion and 
wealth to determine the susceptibility of a country to the epidemic. Therefore, it is 
argued that African countries experience different epidemiological features of 
HIV I AIDS such as different levels of HIV infections, different types of the virus and 
different infected populations. The level and flow of the epidemic may affect HIV 
reduction and treatment. 
32 These factors include timing/early governmental response, political leadership, participation by civil 
society, multisectoral mobilization, balanced prevention and treatment approach, human 
rights/protecting the rights of people living with HIV / AIDS, and transparency of information. 
33 Strand (2007) gives a comprehensive literature review supporting the argument that authoritative 
interventions may generate a more effective response than interventions based on idealistic AIDS 
governance. For instance, while compulsory HIV testing would infringe on individual rights it would 
most likely yield public health benefits. 
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A number of recent studies have begun to unpack and analyze the associations among 
HIV / AIDS and these national characteristics (Nattrass, 2006; A. Patterson, 2006; Bor, 
2007; Lieberman, 2007). For example, a study by A. Patterson (2006) examines the 
relationship between national characteristics and state efforts to fight AIDS. In a 
qualitative assessment, she considers the impact of four state factors: centralization of 
power, neopatrimonialism, state capacity, and security on state efforts to fight AIDS 
in four African countries: Zimbabwe, Uganda, Swaziland and South Africa. She uses 
data from the AIDS Programme Effort Index (API) (United States Agency for 
International Development [USAID], UNAIDS, World Health Organization [WHO], 
& the POLICY Project, 2003) to measure state efforts to combat the disease.34 Her 
findings indicate no clear pattern among these four countries suggesting that not one 
state element determines AIDS efforts more or less than another. She also notes that 
these national characteristics are interrelated preventing our ability to test which factor 
is the most driving determinant of AIDS efforts. While A. Patterson does not 
specifically look at epidemiological features of the epidemic, she begins to look 
systematically at the associations among state characteristics and HIV / AIDS. 
Nattrass (2006) specifically addresses the impact of economic and political factors on 
ART coverage across 77 countries. She considers per capita income, governance 
indicators, region, and HIV prevalence in multiple regressions. Her findings indicate 
that higher levels of per capita income result in greater access to ART coverage. She 
also identifies that efforts to increase access to treatment have been more successful in 
democratically governed countries. Finally, she demonstrates that Latin America and 
Africa are providing better ART coverage than would be expected. Due to the 
complexity of donor funding, she excludes HARF A from her analysis. 
From this literature review, five key variables are identified as possible factors that 
may influence HIV / AIDS reduction and treatment: foreign aid, severity of epidemic, 
state capacity, governance, and AIDS governance. 
The dramatic increase of HARF A in the past decade suggests that donors suppose 
foreign aid to promote effective AIDS responses. I will empirically test this 
34 Since I use the API as a measure of "AIDS governance", further discussion on this index can be 
found on pages 38 of this thesis. 
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assumption while considering the aforementioned national characteristics. The 
following section will conceptualize the independent, dependent, and moderator 
variables. 
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CHAPTER THREE 
RESEARCH DESIGN 
To meet the MDG targets of 2015, UNAIDS projects that the resources needed for 
prevention and treatment will only increase. Poku posits that "the costs of a 
comprehensive HIV I AIDS response for sub-Saharan African countries would increase 
from US$6.8 billion in 2007 to US$ 15.5 billion by 2015" (2006, p. 353). In order to 
encourage governments to sustain these types of increases and maintain the 
prioritization of HIV I AIDS in Africa, donor agencies need evidence that HARF A is 
actually helping the HIV I AIDS epidemic in Africa. We need to explore systematically 
the impact of HARF A on HIV I AIDS whilst considering the influence of other 
possible national characteristics. The general claims that aid works more effectively in 
countries with better state capacity or governance also needs examination. In addition, 
we must consider the influence of AIDS governance and severity of the epidemic. 
3.1 Research Methodology 
The main concepts of this study come out of the literature review in the previous 
chapter. For the most part, theory determined the selection of the variables; however 
one can never avoid the realities of data availability. For example, I was forced to 
exclude behaviour change as an indicator of HIV/AIDS progress because of 
insufficient data. 
I examine the association between HARF A and HIV I AIDS reduction and treatment 
through a quantitative methodology using three types of statistical analyses: bivariate 
analysis, multiple regression analysis and interaction analysis. First, I want to 
establish whether there is indeed an association between HARF A and HIV I AIDS 
progress by testing the bivariate correlations between these variables. Since the 
dependent variable is comprised of two indicators, I examine each separately. I 
conduct a bivariate analysis of HARF A on change rates in HIV prevalence by looking 
at HARF A measured in 1996 in relation to HIV prevalence change from 1997-2003 
across a sample of 16 African countries. I also conduct a bivariate analysis of the 
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relationship between HARP A measured in 2003 and the estimated ART coverage 
measured in 2005 across a sample of 29 African countries. 
I then use multiple regression to detennine if the results produced by the bivariate 
analyses remain after controlling for the impact of the four national characteristics 
identified in the literature review. These factors may not only affect the impact of 
HARF A on the dependent variables, but also have an independent effect on 
HIV I AIDS progress. If this is the case, I will be able to identify which of the factors 
(state capacity, governance, AIDS governance, severity or HARP A) has the strongest 
and most significant impact. 
The last method employed in this research is interaction analysis of the impact of the 
national characteristics on the link between HARP A and HIV I AIDS progress. The 
moderating variables identified in the literature review (severity of the epidemic, state 
capacity, general governance, and AIDS governance) may shape the influence of 
HARP A on HIV I AIDS progress. This study postulates a moderated causal 
relationship. In other words, the nature of the relationship between the independent 
variable, HARF A, and the dependent variable, HIV I AIDS progress, is detennined by 
national context.35 Since the logic of causal order requires the independent variable to 
precede the dependent variables, I measure the moderating variables at the closest 
time point to that of the independent variable (Davis, 1985). For example, I will 
measure the influence of state capacity in 2003 when considering the relationship of 
HARPA measured in 2003 and ART access measured in 2005. Figure 1 visually 
displays the model employed in this study. 
35 I developed the model used in this study from Jaccard and Turrisi (2003). 
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(state capacity, governance, AIDS governance, and the severity of the epidemic) may 
influence the epidemic. The characteristics of a recipient country will most likely 
shape the impact ofHARFA on HIV/AIDS. 
It is unlikely that we will find no association at all between HARF A and HIV I AIDS 
progress. Sub-Saharan African countries rely on HARF A to implement AIDS 
prevention programmes and treatment, and recipient countries, through government, 
civil society and local NGOs, are ultimately responsible for how HARF A is spent and 
allocated. Therefore, HIV I AIDS progress will vary due to the impact of these the 
moderator variables. For instance, African countries that have high state capacity may 
be better able to absorb HARF A more effectively providing greater access to 
treatment. Likewise, countries that have good governance practices may have more 
transparency, openness and information exchanges creating more mechanisms for 
accountability of AIDS spending. Also, more liberal AIDS institutions and a human 
rights based approach to HIV/AIDS may encourage an environment conducive to an 
honest discourse about changing sexual behavior. Finally, countries with severe 
epidemics will have difficulty improving HIV/AIDS conditions even if HARF A is 
available; whereas, countries with lesser epidemics will be able to apply HARF A to a 
smaller population more effectively. 
I also expect to find a reciprocal relationship amongst the variables used in this study. 
As discussed in the previous chapter, A. Patterson (2006) recognizes that the linkages 
between the national characteristic prevent us from identifYing which factors are more 
important for responding to AIDS. Therefore, I anticipate that these factors will be 
highly correlated. In addition, the national characteristics will probably associate with 
HARF A allocations on their own as well as the two indicators of HIV I AIDS progress. 
These reciprocal relationships may affect the final analysis. 
Finally, I expect that the two indicators of HIV I AIDS progress, HIV prevention and 
treatment, will differ. The link between foreign aid and treatment is more direct 
because money for treatment can be directly translated into medicine, health staff and 
educational programmes. Money for HIV prevention programmes however relies on 
behaviour change among individuals. While both indicators depend on a series of 
institutional and bureaucratic factors that need to work well to combat HIV I AIDS, 
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HIV prevention has additional challenges and complications that ART access need not 
consider. As a result, I do not expect HARF A to affect these variables equally. 
3.4 Hypotheses 
Based on the theories identified in the literature review and the above expectations, I 
postulate two main hypotheses. From the second hypothesis, I draw further 
suppositions. 
1) There is a relationship of HARFA and HIV/AIDS progress (i.e. change rate in 
HIV prevalence and ART access). The relationship between HARF A on the 
change rate in HIV prevalence will be negative; the relationship between HARF A 
on ART access will be positive. 
2) The relationship of HARF A on HIV I AIDS progress will depend on the 
characteristics of the recipient country. 
a) HIV prevention: 
i) The effectiveness of HARF A on the change rate in HIV prevalence will be 
greater in countries with high state capacity opposes to countries with low 
state capacity. 
ii) The effectiveness of HARF A on the change rate in HIV prevalence will be 
greater in countries with better governance opposed to countries with poor 
governance. 
iii) The effectiveness of HARF A on the change rate in HIV prevalence will be 
greater in countries with more idealism in AIDS governance opposed to 
countries with less idealism in AIDS governance. 
iv) The effectiveness of HARF A on the change rate in HIV prevalence will be 
greater in countries with less severe epidemic opposed to countries with 
more severe epidemic 
b) ART treatment: 
i) The effectiveness of HARF A on ART treatment will be greater in countries 
with high state capacity opposes to countries with low state capacity. 
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ii) The effectiveness of HARF A on ART treatment will be greater in countries 
with better governance opposed to countries with poor governance. 
iii) The effectiveness of HARF A on ART treatment will be greater in countries 
with more idealism in AIDS governance opposed to countries with less 
idealism in AIDS governance. 
iv) The effectiveness of HARF A on ART treatment will be greater in countries 
with less severe epidemic opposed to countries with more severe epidemic. 
3.5 The Data Set 
I develop a unique database with information from several sources for the purposes of 
this analysis. I extracted HIV/AIDS related foreign aid data for 1996 from a UNAIDS 
report (Ernberg, Opuni, Schwartlander, Walker, Tarantola, & Kieffer, 1999) and 
HIV I AIDS related foreign aid for 2003 from the Organization for Economic 
Cooperation and Development (OECD)I Development Assistance Committee (DAC) 
dataset (2006). I gathered data on state capacity from UNDP Human Development 
Reports (1999, 2005); on governance from World Bank Governance reports (World 
Bank, 2006); and on AIDS governance from the AIDS Programme Effort Index 
(UNAIDS et ai., 2003). For HIV prevention, I used HIV prevalence trend data from 
an article published in the Lancet (Asamoah-Odei, Calleja, & Boerma, 2004), which 
monitors HIV prevalence at the same antenatal clinics from 1997-2003. Finally, for 
treatment, ART coverage estimates were extracted from a report published by 
UNAIDS (2006). 
It is also important that countries with different severities of the epidemic are included 
because HARFA is not allocated solely on the basis of HIV prevalence. For instance, 
in 2005 Nigeria, with 4 percent HIV prevalence, received twice as much HARF A as 
Lesotho, with 23 percent HIV prevalence. In this specific comparison, Nigeria may 
have received more funding because they actually have more HIV -positive people, 1.6 
million, compared to Lesotho's 250,000. I will control for population by using 
HARF A per capita in my analysis. 
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3.6 Limitations and challenges 
At this point, it is vital to identify some of the limitations and challenges of this study. 
One main challenge rests with the data set as described above. I encountered problems 
with the availability of accurate, complete and reliable data. Another challenge comes 
from the fact that there is little consensus on how to measure progress in combating 
the epidemic.36 This section explains the main data concerns and other limitations of 
this study. 
3.6.1 H1V Prevalence Data 
One indicator of HIV / AIDS progress is HIV prevention, which in turn decreases the 
number of deaths due to HIV -related illness. The best indicator of this would be HIV 
incidence, which refers to the annual rate of new infections (de Waal, 2006, p. 109). 
However, HIV incidence is difficult to measure. 37 Due to this limitation, UNAIDS 
prefers to use HIV prevalence among young men and women (15-24) as a proxy for 
HIV incidence. This UNGASS indicator is not yet available over time for a trend 
comparIson. Therefore, I gauge HIV prevention as the rate of change in HIV 
prevalence. 
HIV prevalence can be defined as the percentage of a population estimated to be HIV 
positive at any given point. Adult HIV prevalence, or "people living with HIV", 
considers the overall population while accounting for new infections and AIDS 
deaths. Ideally, a year-on-year average change of adult HIV prevalence would allow 
us to consider the speed of HIV diffusion and the averaged lag time between HIV 
infection and AIDS death.38 However, yearly adult HIV prevalence data is unavailable 
for most countries in Sub-Saharan Africa preventing a year-by-year analysis. 
36 Goal 6, target 7 of the MDGs is to "have halted by 2015 and begun to reverse the spread of 
HIV/AIDS." The MDG indicator used to monitor the new infection rate in a population is the HIV 
prevalence among pregnant women aged 15-24 (WHO, 2005). However, the WHO recognizes that 
"currently, not enough data are available to provide a full trend analysis for this indicator" (2005, p. 
20). 
37 Since HIV/AIDS is a long-wave disease, people often do not know their status until years after being 
infected (Barnett & Whiteside, 2006). Incidence rates are calculated by using prevalence rates from the 
target year to five years past the target year (UNAIDS, 1999); incidence data is only available until 
2001. 
38 This methodology was used by Kennedy in her mini-dissertation (2006). 
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Nevertheless, adult HIV prevalence data has been systematically collected by 
countries since the onset of the epidemic. While country reports vary in quality, 
UNAIDS compiles the data into bi-annual reports (UNAIDS, 1999, 2004b, 2006). I 
collected bi-annual HIV data from these reports, which contain data for 1997, 1999, 
2001, 2003, and 2005. Upon closer examination of the data, it is clear that variation in 
the baselines and other methodological differences prevent trend comparisons of 
different UNAIDS' global reports. 
Due to the limitations of data from UNAIDS, I analyze HIV prevalence trends in 
pregnant women attending antenatal clinics. Asamoah-Odei and his colleagues (2004) 
published results of a trend series study whereby they assess HIV prevalence and 
trends in Sub-Saharan Africa. 39 They use data from the same antenatal clinics in 23 
countries from 1997-2003. There are some limitations of using this study. First, the 
number of clinics observed in each country varies. For example, they used 66 clinics 
in Nigeria but only 5 in Burkina Faso. Second, they combine data or provide an 
average for the first four years of the study, 1997-1998 and 1999-2000, rather than 
reporting annually in order to increase the sample. For consistency purposes, I take 
the average HIV prevalence of 2001, 2002 and 2003. Third, it is not a representative 
sample of the population. Antenatal clinics collect data from pregnant woman aged 
15-49 years however the women attending these clinics may not be representative of 
all pregnant women in the country. Finally, their yearly estimates have overlapping 
confidence intervals, which makes a trend comparison speculative. 
In addition to the limitations of the Asamoah-Odei et al study, there are other 
weaknesses when using the change rate of HIV prevalence. The complexity of the 
epidemiological features of HIV / AIDS makes measuring the level and flow of the 
epidemic difficult. One might consider the type of virus, HIV 1 or HIV 2,40 or one 
could consider the population infected. Some countries experience HIV infection in 
localized populations (commercial sex worker, IV drug users or homosexuals) 
39 The WHO also did a trend study but the baseline measurement (i.e. the number of antenatal clinics 
used) varied yearly creating methodological concerns about the data reliability (Asiimwe-Okiror, 
Ntabangana, Asamoah-Odei, & Calleja, 2005). 
40 HIV -1 accounts for 98 percent of all HIV infection in Africa. It is the variation of HIV subtypes 
(group M, group 0 and group N) that differs among African countries (Asiimwe-Okiror et a!., 2005). 
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opposed to the general population. The population infected with HIV / AIDS can 
determine HIV / AIDS progress, HARFA allocations, and severity of the epidemic. 
We also know that reduction in HIV prevalence takes a long time.41 With an increase 
of ART access and use, HIV prevalence may actually increase due to the combination 
of new infections and the longer life span of the current HIV -positive population. 
ART roll-out drastically improved throughout the region only after 2001 due to 
increased funding. The upsurge of treatment will minimally influence the change of 
HIV prevalence for this study because the Asamoah-Odei et al report concludes in 
2003. In addition, a decline in HIV prevalence does not tell us whether rates are 
decreasing due to AIDS deaths or due to emigration nor does it consider that countries 
may be at different levels of the epidemic (Barnett & Whiteside, 2006). The difficulty 
of epidemiologically monitoring the progression of the HIV / AIDS epidemic presents 
many challenges for scholars, donors and institutions (UNAIDS, 1999). Despite the 
many weaknesses of using the change rate of HIV prevalence as an indicator, it is the 
best data available. 
3.6.2 HIVIAIDS relatedforeign assistance data (HARFA) 
The complexity of foreign aid is vast and difficult to measure. Foreign aid is fed 
through multiple channels for different purposes, and donors can include bilateral and 
multilateral funding agencies, private foundations, grant -making institutions, or 
corporate philanthropy. As Nattrass points out "donor assistance takes many forms, 
ranging from direct transfers to government (World Bank), to developing close 
partnerships with governments (for example, Medecins Sans Frontieres' support for 
government clinics in Khayelitsha, Cape Town) or to setting up separate operations 
with faith-based organizations (as is often the case with PEPFAR-funded projects" 
(2006, p. 327). The conceptual and operational framework of foreign aid presents 
many challenges as it is difficult to trace in its entirety. 
F or this study, HIV / AIDS related foreign aid, HARF A, is measured as official 
development assistance (aDA) given specifically for HIV / AIDS control as recorded 
41 For more information about the specific case of Uganda's efforts in reversing the HIV/AIDS 
epidemic please see de WaaI (2006, pp. 108-110). 
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by major donors through the Organization for Economic Cooperation and 
Development (OECD)/Development Assistance Committee (DAC). There are several 
limitations to this measurement of HARF A. Firstly, measures of foreign assistance 
track what donor countries report giving and not how much aid goes directly to 
poverty reduction, relief, or HIV I AIDS programming through developing countries' 
national budgets or NOO sectors. A UNAIDS study tracking HARF A demonstrates 
that what countries report receiving often differs from what donors report giving 
(Ernberg et aI., 1999). However, poor national accounts data with regard to public 
health and HIV/AIDS,42 force me to measures funds committed by donors rather than 
funds dispersed.43 
A second limitation stems from the fact that ODA includes things like payments to 
US based consulting organizations, debt cancellation grants (which is not new money 
but the subtraction from what was owed), emergency assistance (which often has a 
higher cost of transportation than normal aid), technical assistance and small donor 
"pet projects" (Sachs, 2005b, p. 80). We must therefore recognize that according to 
my definition of HARF A, the money and resources reported by OECD/DAC are not 
entirely going directly to recipient countries. It can also be assumed that there is 
variation of aid allocations within countries. While a more expensive analysis should 
attempt to control for this variation, it lies beyond the limits of this thesis. 
A final limitation of this measure of HARF A is that it excludes private and 
nongovernmental aid. Yet despite a recent increase of private donors like the Oates 
Foundation, Figure 2 demonstrates that official bilateral aid still comprises the lion's 
share of resources to HIV/AIDS. Sachs claims that "for many African countries, ODA 
is still the largest source of external financing and is critical to the achievement of the 
development goals and targets of the Millennium Declaration and other 
internationally agreed development targets" (Sachs, 2005a, pp. 217-218). With the 
advancement of bilateral aid initiatives such as PEPF AR, it can be assumed that ODA 
42 Many African countries have not conducted National Health Accounts or systematic studies to 
estimate health spending on HIV/AIDS (Levine & Blumer, 2004). 
43 The Centre for Economic Governance and AIDS in Africa is currently training and implementing 
HIV / AIDS budget tracking programmes in many African countries in order to improve this data. 
Countries will be reporting on this indicator for the UNAIDS 2008 Global AIDS Report. 
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melhods and sample size oftcn diffcr resulting in different measurements for the samc 
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ARr c"y~rag~ is a prime example "f dala reporting variation. In lhe I:NAI DS ~()()(i 
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CHAPTER FOUR 
CONCEPTUAL AND DESCRIPTIVE FRAMEWORK 
In this chapter, I give HIV/AIDS related foreign assistance (the independent variable), 
HIV I AIDS progress (the dependent variable), and the moderator variables specific 
and operational definitions. I then analyze each variable separately before finally 
addressing the relationships amongst them. How do we measure HIV I AIDS progress? 
What types of foreign aid should be included in the study? Are countries generally of 
the same levels of wealth? Do they experience differing qualities of governance? 
What is the general level of idealism in responding to the epidemic? Does the 
epidemic vary across the 29 countries? 
The first part of this section will address HIV I AIDS progress. Second, we will look at 
aid in support of HIV I AIDS as the operationalization of HARF A. Finally, we will 
unpack the moderator variables. 
4.1 The dependent variable: HIV/AIDS progress 
HIV I AIDS progress can be conceptualized in two ways. The first refers to policy 
development of the "best practice" guidelines produced by UNAIDS for an effective 
response (Lieberman, 2005).45 An alternative conceptualization understands 
HIV I AIDS progress in epidemiological terms: reducing HIV prevalence, providing 
treatment and care, and reducing risky behavior. For this study, I define HIV/AIDS 
progress as positive change in the epidemic itself and the actual outcome of what 
governments and other stakeholders are doing about the epidemic. My attention is on 
the epidemic by means of prevention and treatment, which is in part an outcome of 
HIV I AIDS policies. I will focus this study on two variables: HIV prevention and HIV 
treatment,46 I will define each of these concepts and operationalize the terms using the 
45 Donors (i.e. the G8, the World Bank and UNAIDS) produced a national AIDS response template 
modeled from the successful responsive programs in Uganda and Senegal in order to monitor national 
AIDS responses (Lieberman, 2005) 
46 I have left behavior change out of this study due to data limitations. 
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best data available to me. Where possible, I have tried to use the HIV/AIDS indicators 
identified by the MDGs in order to generalize this study for future research.47 
4.1.1 HIV prevention 
I measure the HIV prevention variable as the average bi-annual growth rate of 
antenatal clinic (ANC) HIV prevalence in a country. To calculate the change rate of 
HIV prevalence, I measure bi-annual on bi-annual ANC HIV prevalence growth since 
1997 (the first available HARF A data is from 1996). Examining HIV trends 
subsequent to the independent and moderator variables, causal time-order is 
established allowing us to examine causality (Davis, 1985). 
HIV prevention will be measured by the average bi-annual rate of change in HIV 
prevalence from 1997-2003. A country that experiences a reduced or decelerated HIV 
prevalence will be considered as having HIV I AIDS progress rather than a country 
with an increased and accelerated rate of HIV prevalence. Asamoah-Odei and his 
colleagues provide ANC HIV prevalence trend data for 16 countries (Appendix A).48 
They combine data for 1997 and 1998 as well as 1999 and 2000 providing five time 
points. I calculated the average of 2001, 2002, and 2003 to make the data more 
comparable over time. 
Figure 3 illustrates line graphs of national rates of change in HIV prevalence from 
1997-2003. Figure 4 shows the average percentage change. For the most part, the 
surveyed antenatal clinics within the sample experience little change In HIV 
prevalence. Botswana, Mozambique and Namibia experienced increases of HIV 
prevalence; whereas Uganda and Kenya experienced the greatest declines in HIV 
prevalence. Malawi, Tanzania and Zimbabwe have initial increases and then 
considerable decreases of HIV prevalence resulting in a small overall percent change. 
From Figure 3, we can also see the different initial HIV prevalence across the 16 
countries. 
47 In addition to the MDGs that are highlighted in this paper, the MDG for HIY/AIDS also considers 
orphans and vulnerable children as an indicator. I have excluded this indictor not because I think it is 
unimportant but rather to minimize this study for a master's level thesis. 
48 The study actually provides information for 23 countries however HARF A 1996 data only overlaps 
with 16 countries, which reduces the sample size (Asamoah-Odei et a!., 2004). 
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discrepancies in the reporting of ART coverage. I use the WHO data for this study 
because it reports on the most countries and is used by Nattrass (2006). 
The World Bank governance indicators provide an example of data inaccuracy 
because these measures have large margins of error causing an overlap of governance 
measures in many African countries. Daniel Kauffman, Director of Global 
Governance at the World Bank Institute, and Aart Kraay, Lead Economist in the 
World Bank's Research Group, acknowledge that governance is difficult to measure 
and is not fully reliable, but they defend their method used to determine governance 
indicators. Kraay says, "A key feature of our governance indicators is that we make 
every effort to be transparent about the degree of imprecision... Because we 
aggregate information from many different data sources, our indicators are more 
informative than any individual data source" (World Bank, 2006). Consequently, 
World Bank Governance Indicators are the best to measure levels of governance 
despite the flaws. 
3.6.4 Number o/Cases 
A final limitation of my study is the number of cases. My first analysis of HARF A 
and the HIV prevention analyses 16 countries: Botswana, Burkina Faso, Congo DR, 
Cote d'lvoire, Ethiopia, Ghana, Kenya, Malawi, Mozambique, Namibia, Nigeria, 
Senegal, Tanzania, Uganda, Zambia, and Zimbabwe. The second analysis ofHARFA 
and ART access considers 29 countries, which include the previous countries and 
adds: Angola, Benin, Burundi, Cameroon, Chad, Congo, Lesotho, Madagascar, Mali, 
Rwanda, South Africa, Swaziland and Togo. These countries are chosen based on data 
availability and are not intended as a representative sample of the African continent. 
Thus, I will not make general claims about HARF A across the continent, but rather 
explain the situation of these 29 countries. 
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4.1.2 HIV treatment 
My second indicator of HIV/AIDS progress consists of access to HIV treatment. I 
measure this second dependent variable as the estimated antiretroviral therapy (ART) 
coverage as of December 2005. Generated by UNAIDS and WHO, these estimates 
calculate the "number of people with advanced HIV infection who receive 
antiretroviral combination therapy in accordance with the nationally approved 
treatment protocol (or WHOIUNAIDS standards)" (UNAIDS, 2006, p. 584). In other 
words, ART coverage refers to the estimated percentage of people with high levels of 
HIV, most likely with symptomatic AIDS-related illnesses, who have access to 
antiretroviral medicine. Another way to think about this variable is treatment provided 
as a percent of the demand. Even though it does not distinguish between the types of 
treatment or the cost of the treatment, it is the best available indicator to compare 
ART access cross-nationally. 
Unlike herbal or medicinal treatment for HIV/AIDS, ART has been medically proven 
to reduce the HIV viral load in a person living with HIV I AIDS allowing a person to 
live longer (Gallo et aI., 2006).49 Access to ART is crucial to preventing the spread of 
the epidemic, especially mother-to-child transmission.5o Treatment transforms 
HIV I AIDS from a "death sentence" to a manageable chronic illness. African countries 
that provide more treatment to people who need it experience more HIV I AIDS 
progress than countries that provide little treatment. 
Figure 5 presents the level of ART access in the 29 African countries. The mean is 24 
percent suggesting that a fourth of the people living with AIDS in these countries 
receive treatment; or in other words half of the countries satisfy less than a quarter of 
the demand. Two countries, Botswana and Namibia supply far more ART access to 
people living with high levels of HIV infection than the rest of the sample (twenty 
49 For further infonnation about this debated issue, please see Farber (2006) and Gallo et al. (2006). 
50 Goal 8, target 17 of the MDGs indirectly addresses access to HIV / AIDS treatment, "in cooperation 
with phannaceutical companies, provide access to affordable essential drugs in developing countries" 
(WHO, 2005). 
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The OECD/DAC monitors and tracks all ODA from states. ODA systematically 
measures the sum of grants and loans given to developing countries by developed 
countries to promote economic development and welfare. It excludes military aid but 
includes grants such as PEPF AR and the Global Fund. The OECD/DAC maintains a 
transparent database called the Creditor Reporting System (CRS) that tracks and 
reports aid flows. The database includes foreign aid commitment and disbursement 
summarized by country (donor or recipient), year, or purpose on aid (the development 
target). This data source has previously been used by Powell-Jackson, Borghi, 
Mueller, Patouillard, and Mills (2006), who use the CRS database to track ODA for 
health activities which benefit maternal, newborn and child health in order to assess 
progress of the MDGs for child and maternal health. The logic that countries 
receiving more donor assistance, as measured by CRS, specific to a health problem 
(i.e. maternal and child health or HIV/AIDS) will produce better health outputs is the 
bases for using ODA as a measure of HARF A. 
I use information reported by the OECD/DAC on ODA for HIV/AIDS control to 
operationalize HARF A. I consider the impact of HARF A at two time points: 1996 and 
2003, to analyze the impact of HARF A in 1996 on change rate of ANC HIV 
prevalence from 1997-2003 (hypothesis 1) and the impact of HARF A in 2003 on 
ART access in 2005 (hypothesis 2). The 1996 HARF A data is extracted from a report 
published by UNAIDS and the Harvard School of Public Health called "Level and 
Flow of National and International Resources for the response to HIV I AIDS, 1996-
1997" (Ernberg et aI., 1999). However this report only includes nineteen Sub-Saharan 
African countries, sixteen of which overlap with the sample from HIV prevalence 
trend report. I collect data for HARF A in 2003 from the CRS database called 
"HIV I AIDS Aid Activities", which tracks ODA and other public sector aid specific to 
HIV/AIDS control (OECD/DAC, 2006).52 The amount of foreign aid received for 
HIV/AIDS control considers all aid flows from all OECD donors (as recorded by 
donors). Since data is available from 2000-2005, I take an annual average 2003-2004 
in order to provide a more accurate figure of ODA for HARF A (please refer to 
52 For an analysis of the quality of HI VIA IDS data from the OECDIDACICRS database, please refer to 
OECDIDAC and UNAIDS (2004). 
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Appendix B).53 I assess HARF A as a per capita measure to control for the population 
size variation, which permits a more general comparison between countries. 
Figure 6 and Figure 7 chart HARF A data across the countries I will analyses in this 
study. The difference in HARF A per capita between the time points reflects the 
increase of HARF A in the past decade. In 1996, countries received an average of 
twenty-five cents (US) per person for HIV/AIDS related assistance whereas they 
received almost four dollars (US) per person by 2003. Also, the 2003 data shows the 
influence of PEPF AR on HARF A. The majority of the countries in the top half of the 
sample represent PEPF AR "focus" countries. 54 To recall from chapter two, these 
countries receive significantly more bilateral foreign aid for HIV I AIDS from the US 
than non-focus countries. 
As with most foreign aid studies, I take the logarithm of the HARF A per capita 
measurements (Log HARF A 1996 and Log HARF A 2003) due to the unequal 
distribution of the measurements. 
53 Appendix B also provides regional trends of HARF A. From these graphs, it is clear that HARF A 
changes drastically year to year in many countries, and an average of the two years is the better 
indicator for HARF A. 
54 The PEPF AR focus countries are Botswana, Cote d' I voire, Ethiopia, Ghana, Haiti, Kenya, 
Mozambique, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Uganda, Vietnam, and 
Zambia. 
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-1.3 Th e mod erator varia hies: national clm nlctcristics 
Ideally. we would like 10 aSSllm~ thm mor~ HJ\RFA produces better HI\' outcomes. 
How~ver. the literatur~ cites sevnal nalimml charaLl~risties that may intlucnce this 
relationship, i.e. stat~ capacilY. govtmanc~, AIDS goy~mancc, and seyerity of the 
Lpid~mic. These contextual or mo,krator yariahks also l1~cd ~p<:~ilic ddiniti<)ns and 
Tl1casurcm~nts. In this section. tht l(lUT cOl1texlual variabk~ wil l h~ ~<)nc~ptl1alized 
and op<.:rationaliz~d. 
4.3.1 Slale Capacif)' 
Pric~-Smith al1d his coll~agues expl<)rc 11K: cfJ(;cl of slatc capacily on HIV incidence 
and find that countrits with high~r Icvds <)f ~tatc Lapa~ity expcrienc~ a r~dUClion ill 
HIV il1cidel1ct (2004), Bomming Ii-om olh~r scholar:s, lhty ddine stale capacity as a 
"coul1try's ability to maximi~.~ lIs prosperity and slability, to ~xert de(acro al1d dejure 
control over its telTi10ry. 10 pf()tect i ls populalic.lTl I'i-<)m pr~dmion, to ~Xlraet resources, 
to rq;ulate social relationships. and 10 adapt 10 di\'n"~ crisc~" (2004, p. 152). State 
capacity refers to the ability of a g(l\~rnmenl to salislY its Ilational ne<.:ds; which in 
Sub-Saharan Africa. includes Ihe rl<'ed to COlllrol HIV/AlDS. While th~ relationship 
between public health al1d statt cap""ily ~all \\nrk ill hOlh dir~cliolls (stuuies also 
demonstrate that Il]VIAIDS limits slak ~apadty) \l, lh~ fO~l1" of this studv IS 
cnllc~med witb the innuenc~ of SWlt capacity Oil Ih~ rciali(lTl,hip f>d"C~ll HARI' A 
allU the HIVIJ\IDS epidemic. 
Slat~ ~apocity aims to capture thc actual ability of a CCHlI1tl)' in ttnlls 01' LC()JI01nl~ 
str~ngth. inrraslmLtur~. social capital. and provision. Thtrt ar~ multiplt indicalor~ 
lhat ""<)l1ld ~ml~~ptuaJiz~ this variable such as: Gross Domestic Pf()dlLc! (GDP) per 
capita. gross school cnrohn~nl, h~alth cxp~IllJiture per capita. access to 
~onl1nLJni~al.iol1, distan';~ fwrn ncar~SI health facility. quality of roads al1d l1umb~r or 
dodor, p~r I ,non p~opk It would be eXpI.?ded that countries with mort: ,,·eallh. 
higher health sjXndil1g, more doctors. ktkr ~ducatiol1 and inlclm"nion ~haring ,,,)uld 
." For example. Mo""i"g (2()()3) ~,am illC" the imp""t of j 11 V/AlDS ~n " highly infecled mLlllicipalily 
in Kw,,/ulu- NoLL!' SWlh Africa, where she Jetermino, (hal jjjV willnegali, ely ol1"eCl lh. i()CaJ 
~n"emmon["' capacil)' to gowm and ['<Qvide ,er"ice,. Picase I'of~r {Q Llarn<n .nd WllKe, j(\e (2(1(1(,) 
and de W,,,I (2006) enr adiscu"i"" nfolher impact ;tuJic's 
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expenence greater HIV / AIDS progress. I attempted to create an index of these 
variables to mirror the study done by Price-Smith et al. (2004) however I encountered 
problems when collecting data for the 29 country sample. I did however collect data 
on GDP per capita, health expenditure per capita, physicians, school enrolment and 
phone subscribers. Even though these variables are highly correlated, the different 
forms of measurement and the use of logarithm transformations for some but not all 
of the variables prevented me from using a workable index for this variable. 56 
Previous studies use GDP or Gross National Income (GNI)57 per capita In their 
analysis of AIDS responses (Bor, 2007; Lieberman, 2007; A. Patterson, 2006; 
Nattrass, 2006). GDP per capita measured at PPP (purchasing power parity) reflects 
the economic activity of a country and resources available to the population. GDP per 
capita also indicates the level of development or living standards of people in the 
developing country. My intention is not to ignore the complexity of state capacity but 
to provide an uncomplicated measure for this variable. Therefore, I operationalize 
state capacity with GDP per capita. 
I collect data for this variable from Human Development Reports (UNDP, 1999, 
2005).58 Since the interest of this variable is the capacity of the state to absorb and use 
HARF A, I consider the year in which the aid was received. I measure state capacity 
according to the two HARF A time points: 1996 and 2003. Figure 8 and Figure 9 show 
the range of GDP across the countries in this study for the two time points. Botswana, 
Namibia and South Africa have the highest levels of state capacity; whereas Malawi 
and Tanzania consistently remain with the lowest levels. The average GDP per capita 
ranges around US$ 2,000 for both time points. 
The GDP per capita variables are transformed to logarithms (Log GDP per capita 
1996 and Log GDP per capita 2003) due to the extreme cases that skew the data. We 
can recognize that this variable requires transformation because the mean is 
56 The GDP (PPP) variable and the public health expenditure variable are measured in per capita and 
would need to be logged; the gross enrolment in primary school is a percentage, and the telephone and 
physicians variables are ratio measurements. 
57 GNI includes external resource flows including donor assistance. In order to capture country level 
wealth separate from foreign aid, I use GDP for this study. 
58 I used different Human Development Reports for the different years of the study. For example to 
measure state capacity measured at 1996, I used GDP per capita at 1997 (HDR, 1999). 
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4.3.2 Governance 
Scholars, such as Hsu (2005) and D. Patterson (2001), acknowledge the importance of 
good governance for an effective AIDS response. Both Nattrass (2006) and Halperin 
et al. (2005) empirically demonstrates that more democratic governments provide 
greater ART coverage and experience lower HIV prevalence (respectively). In 
addition, donor agencies are influenced by the quality of a country's governance when 
they make decisions about investing in development because they believe that 
development assistance works best when it is targeted towards countries with 
relatively sound and/or improving policies and institutions (Kauffman & Kraay, 
2002). 
Governance can be defined as "a set of values, policies and institutions by which a 
society manages its economic, political and social processes at all levels through 
interaction among government, civil society and private sector" (Cheema, 2000). It 
describes political systems and the interactions among the players within that system 
and not the system itself. In an attempt to link good governance to economic growth 
and positive development, the World Bank developed six indicators measuring 
different aspects of governance across countries: 
o Voice and Accountability-a measure of political, civil and human rights 
o Political Stability and Absence of Violence-measures the threat of extra-legal 
challenges to the state. 
o Government Effectiveness-measures the efficiency and competence of the 
public bureaucracy. 
o Regulatory Quality-measures the presence of market-unfriendly policies and 
the extent of government regulation of markets. 
o Rule of Law-a measure of the respect for contract and property rights; and 
includes crime rates. 
o Control of Corruption-measures the "exercise of public power for private 
gain" (Kauffman & Kraay, 2002). 
For all six indicators, higher scores indicate better governance outcomes. I use these 
World Bank indicators to operationalize the governance variable. 
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The World Bank uses the indictors to grade countries on a scale from -2.5 to 2.5, with 
higher values corresponding to better governance outcomes (Kauffman & Kraay, 
2002). Theoretically, it would be expected that governments rank similarly on these 
different indicators of governance based on the type of regime in power and other 
factors specific to the country (i.e. conflict or stability). This theory can be supported 
empirically. The correlations among the governance variables are strong indicating a 
relationship amongst them (see Appendix D for the data sets). Factor analyses and 
reliability tests also confirm that the inter-correlations among these variables are 
sufficient for the creation of indices. 59 As a result, these variables can be reduced into 
two governance indices that measure general national governance over the two time 
points: 1996 and 2003. 
The Governance Indices rank countries according to political freedoms, stability, and 
delivery of services. Figure 10 and Figure 11 show the wide range of governance 
scores in Sub-Saharan Africa at the two time points. Botswana and Namibia rank the 
highest on the governance scale while the DRC scores the lowest. Zambia is the 
closest to the sample average, which is -0.6. For some countries, the governance 
levels remain similar over time; however there are many exceptions such as 
Zimbabwe, Burundi, Benin, and Cote d'Ivoire. 
S9 For the factor analyses of the Governance Indices, I used the maximum likelihood extraction and 
direct oblimin rotation. The 1996 Governance variables produce an Eiganvalue of 3 .797 explaining 
63.3% variance. The reliability test shows a Cronbach's Alpha of .869. The 2003 Governance variables 
generate an Eiganvalue of 4.918 explaining 82% variance. The reliability test produces a Cronbach's 
Alpha of .947. 
Un
ive
rsi
ty 
of 
ap
 To
wn
, .~ .. 
-
",.wi 
"'''',,",'' ''" 
"'"'"." , . ,." 
".,..,,,.,,¥ ,,_. 
~"' .. 
C~"'" "" . ~. 
~.-, ... , 
C." , . M,~ . M_"_._"" 
~ ,,.". 
, " .M"" 
.-. 
Mo._"~, ". 
,"0. _ ," 
c.~_.~". 
"""-
K _V" 
,,--- -
,,~ .. -
c_ • • 
~ .. ,,-
"_ . -,. "." 
~-.-" 
• 
Go .. "",,, . ,,!>! 
-------,---
_l' , 
,_ "" ~~~ •• """ "'o ~ 
-----~ 
" 
O' 
." 
•• 
O M 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
4.3.3 AIDS Governance 
According to Strand (2007), AIDS governance is defined as the type of national 
response to the HIV I AIDS epidemic (idealistic, authoritative, or authoritarian). 
UNAIDS and other such institutions promote idealistic, or human-rights based, 
responses; whereby they argue for protection of people affected by HIV I AIDS 
through formal policies, laws, and regulations and presume that an expanded human 
rights environment positively affects service outputs and utilization (USAID et aI., 
2003). In a joint effort to measure the national AIDS responses, USAID, UNAIDS, 
WHO, and the POLICY Project developed the AIDS Programme Effort Index 
(API).6o The API measures "Program Effort" across ten components: political 
support; policy and planning; organizational structure; program resources; evaluation, 
monitoring and research; legal and regulatory environment; human rights; prevention 
programs; care and treatment services; and mitigation programs. 
The "national program," as understood by the API, involves efforts by the 
government to respond to the HIV I AIDS epidemic. Lieberman (2005) describes the 
API as a measurement of the "Geneva Consensus", or a list of rules and regulations 
put out by UNAIDS. The application of the API indicates that these donor agencies 
believe that certain policies, programmes, and government actions are the best course 
for governments to respond to HIV/AIDS. Since the components of the API seek to 
measure participation, accountability, service delivery, responsiveness and human 
rights, it can be argued that the institutions that administered the API encourage a 
more idealistic form of AIDS governance, as described by Strand (2007). 
The level of idealism in national AIDS responses may influence HIV I AIDS progress 
and the effectiveness of HARF A. Donors administer the API in order to determine 
how well countries are responding to their epidemics. They assume that countries with 
more idealistic responses to AIDS will spend foreign aid more effectively because 
they follow the "rules" i.e. they have laws protecting individuals affected by 
HIV/AIDS, involvement of civil society, maintain care and treatment programmes, 
60 Using the key informant method, a national consultant (an expert in the field of HIV I AIDS outside of 
the national HIV/AIDS program) researched answers to a questionnaire through personal interviews 
with people working in the field. 
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1.'1<: .•• To opcmtiollulize the concepl or AIDS governan<:c. I uSC the national /\1'1 
,cores "h..-:r..-:hy high..-:r srores will coincide wilb greater lcwb or idealism 11\ AIDS 
t\0\,..-:rnanec. 
Despite some methodological concerns nnd limited ~ccess to the complete data~d.61 
the Al' l is the hest availahic indicator of AIDS go\'crn~nce. The inclusion or the A IDS 
gm'Cl"Tluncc var iable 1111<) Ih..-: analysis wi ll allempllO discern IWO question~. Fin;l. ! 
will wanl to delermin..-: ifthcre is u relution,hip betwcen the Jlnonnt <A' jIARFA a 
country rec..-:i\'es and Ih..-:ir API score, Second. I will deternline ir the API vari~ble 
modi lies the impact of iiAlnA on nn dfective nulionJI AI DS rcs[lOnse. 
Fig"H' 12: AlliS 1',,,~r:Utl nt< Eft"rt htd« 2003 
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Figure 12 di~play~ the n~tiOIl"-1 Al' l ""or..-:s und demonstrates a siliall range (42 point 
dilference) of scores across the 2') countries. Region docs not seem to in!lucllce the 
scale since the lOp five ~Ild haltom fi\'e countries reprcscnt different regions, The 
uwruge !\Pl se<.>re is 64. which ["a lb octween Tan/.'-ll1i~ and 7ambia. Uganda and 
," lile ,,,,il,bk dowse l r.<:exd , the "s<"ro" j"I' each ,0011)(">0111 oflhe APt. It d"", l~" li'llhc <lata for 
erICh qllestioll "'lod in tbe survey. "hid, ,,,,,id 1m'. beell IIsotLlI ill ;",Iating 'pcc ; Ii< mc'''mCm",~, of 
AIDS gO\ CtTl""C~, ",ch "' pot1icipmicol "f <ivil we iety, 
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Senegal, which are often cited as the "success stories" of AIDS governance, are in the 
top quarter of the API along with Botswana, Rwanda, Burkina Faso, Malawi, and 
South Africa. Lesotho has the lowest score. The subjective nature of the API (i.e. 
personal interview of experts by an in-country consultant) raises some problems with 
using this data. Therefore it is difficult to distinguish the difference between a score of 
66 or 67. 
4.3.4 Tlte severity oftlte HIVIAIDS epidemic 
As noted in chapter two, the state and extent of the HIV / AIDS epidemic varies across 
Sub-Saharan Africa. The different levels and trajectories of the epidemic may shape 
foreign aid allocations and national AIDS responses. For instance, a country with a 
high and growing level of HIV prevalence will need to provide treatment to a larger 
percentage of its population, which requires more funding. In contrast, a country with 
a low and static epidemic may be more likely able to apply HARF A effectively since 
a smaller number of people are infected. The severity of the epidemic tells us whether 
HIV / AIDS is manageable or not. 
For the purpose of this thesis, I attempt to capture the actual extent of the national 
HIV / AIDS epidemic and ask a simple question: are countries faced with severe or 
mild epidemics? While this simplification creates some limitations, it at least provides 
an empirical way to recognize that countries experience different levels of the disease. 
To operationalize severity, there are several options. First, I could look at the overall 
HIV -positive population within each country. However, this would not take into 
account national population size. To address this, I could use the percentage of adult 
HIV prevalence; however, these figures change thorough time as countries experience 
an increase or decrease of HIV infections. For example, Burundi, Cote d'Ivoire, 
Ethiopia, Kenya, Rwanda and Uganda faced more severe epidemics in the late 1990s 
yet experienced a decline in HIV rates. Even though these countries currently have 
lower rates, they had to cope with more severe epidemics in the recent past. 
Therefore, the use of HIV prevalence at the time of HARF A allocation (especially for 
the treatment analysis where HARF A is measured in 2003) would not capture the 
intention of the severity conceptual framework. 
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To operationalize severity. I diyide COllntries inlo 1\\0 groups on tile basis of (heir 
HIY/AIDS prevalence over an eight year time ~pan. ReCill1~~ l.Jl\A1DS uo~uments 
national HIY prevalence since 1997, I employ their meilSur~menl, <I~ il sourc.e oflhe 
uata (UNAlDS. 1<)<)9, 200--lb, 20(6) and llse the highesl e'er 1l1Y previll~nLe r<lle in 
Ihe PilSt ~ight years as an inuicator of "mild" or "scyere" epidemics. Counlries with 
high lilY prevalence (oyer 10"/0 of the population at any point from 1997-2005) l"oce 
"scver~'" ~pidemi~s; whereas, countries with low lilY preyalcnce (below 10% of the 
population at any point from 1'i97-20(5) face "'mild" epidemics. \l,.'hilc recogni/.ing 
th<lt lhi~ ildmiuedly arbi trary c.ut-off point has no scientific or theoretkal backing, two 
iu;<ld~mi~ papern LISe this mcthod in thcir \\ork. whieh provides precedent, (or its 
usage in thi~ ~tlIdy (H~l1. 20()5; Stranu & \ialles, llnpllhlisheu). Table 1 as,igns 
~OUlJlri"" lh~ ~a!egory of ~eVCIT epiuemic Or mild epidemic and separates COlll1lneS 
region<llly. 
,:, ·I _Mild_ Severe 
Southern Africa , Botswana 
Lesotho 
Ma:a"" 
Mozambique 
Namib", 
South Afrk:a 
Swa~ii<lnd 
Zambia 
Angola Zimbabwe 
-
East Afr ica Madagascar f>urundl 
Tan7ania ~tilloria 
Uganda Kenya 
Rwanda 
~e;;traI IWest f>enln Cote 
Africa f>LJrklna D'ivoire 
Faso 
CamN0C<1 
Chad 
Congo 
ceo 
Ghana 
, Mali 
Nigeria , 
Sonegal 
I Togo 
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In addition to addressing the severity of the epidemic, this division also reflects 
regional differences. For example, East African countries mainly face "mild" 
epidemics while Southern African countries experience "severe" epidemics. This 
chart confinns global reports that Southern Africa suffers from high levels of HIV 
infection. Eastern Africa currently has a mild epidemic but previously half of the 
countries in this sample had severe epidemics. Central and Western Africa has 
consistently faced a mild and controllable epidemic. 
At this point, all concepts have been defined and operationalized for this study. On 
their own, the descriptive findings provide rich infonnation such as which countries 
have experienced an increase or decrease in HIV prevalence or how much ART 
coverage a country provides. It is also interesting to "eyeball" where countries rank on 
each of the national characteristics indicators. Yet the wealth of this infonnation 
requires systematic and statistical comparison. The next chapter will empirically 
examine the relationships among the variables identified and discussed in this chapter. 
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CHAPTER FIVE 
RESEARCH FINDINGS 
Based on the research questions and hypotheses developed from the literature review, 
this chapter will empirically examine the relationship between HIV / AIDS related 
foreign aid and the two indicators of HIV / AIDS progress: HIV prevention and 
treatment. First, I will observe the associations of HARF A and HIV prevention and 
then HARF A and treatment. Second, I will discuss the importance of the four national 
characteristics, identified by scholars, which may inf1uence HIV / AIDS progress. 
Some emphasize state capacity and wealth; others identify good governance; a new 
school of thought separates AIDS governance from governance; and some scholars 
argue the importance of the level and intensity of an epidemic. Since these national 
characteristics are important, the third section will consider the individual impact of 
each factor on HIV / AIDS progress. Following the bivariate analyses of these 
associations, the fourth section will use multiple regression analyses to determine the 
most inf1uential determinant of HIV / AIDS progress. The final section explores the 
effectiveness of HARF A by considering the interaction effect of these national 
characteristics on the relationship between foreign aid and treatment. 
5.1 The impact of HARFA on HIV/AIDS progress -bivariate analyses 
In this section, I examine the main question of the thesis: what is the impact of 
HIV / AIDS related foreign assistance on HIV / AIDS progress? Since I operationalize 
progress with two indicators, I will begin by assessing each separately.62 First, I look 
at the effect of HARF A measured at 1996 on the average percentage change in HIV 
prevalence from 1997-2003. To recall the logic of this examination, AIDS funding is, 
in part, directed at prevention campaigns. I use the indictor, change rate of HIV 
prevalence, to capture the concept of prevention as an outcome. It would be expected 
that countries with more HARF A in 1996 had more funding and hence more 
successful prevention programmes, which resulted in a decline of HIV prevalence. In 
statistical terms, I expect to find a strong negative association between these variables. 
62 The two indicators of HIV / AIDS are not statistically correlated. 
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With regards to the se~ond indicator or HIYiAIDS progr~ss, I consid~r th~ eff~ct of 
HJ\ RFJ\ m~a~ur~d at 20m 00 antiretroviml tl~rapy (ART) a~c~s~ m~"sured at 2005, 
The rea~ming lor this a~ses~m~nt presupposes that J\IDS funding all o~aled to 
treatment programmes puts more people 00 lifesaving drug~_ In statistical t~mls, I 
~xpect to lind a ~trong posl ti,,~ re latlonship bet"e~n HARFJ\ and ART a~~~s~_ To kst 
these hypotheses, I use bivariate cOlTelat ions (Pearson's R) and scalier plo ts or the 
variables to empiriclIlIy test these rdationships, 
5,1.1 HI VIA/f)S relatedfilreign assistallce IIml the rule l)f chllnge ill HI V 
premfcllce 
For the first indicator of HI\' progress, this analysis s<:eks to ass<:ss th~ impact 01' 
AIDS funding on HIV prevention. An examination 01' the scatter plot 01' log llAKfA 
,md ~hange rate in HIV prevalence (Figure 13) reveals no pllttern be tween llARFA 
and ~haoge nll~ "ithin the sample. This is confirmed by a VCI)' weak bi'ariat~ 
a~so~iatioo (P~arson's r = -0,07,:)). While this correlation is negative as hyp<J1l~si/ed. 
the probabil ity or this "s~ociat ion is \'~ry low_ Ihe relationship octween BARF;\, 
measured in 19<J6 and th~ dmng~ rale in HI\' prevalence 1'Y'!7-1003 is weak and 
~ tat i sti~a ll y ;n~ignificanL 'Ihese findings sugges t no pattem between a<klitiooal 
in~r~men(s or AIDS runding in I '}96 and HIV reduction between 1 ':)<)7 lind 20eU. 
Figure 13: S<.lIte 1'1,,1 "r L,,~ Jt '\ I{~ A 19% and «~lange rate of III V prr' alrner t QQ7-200J 
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We can gain a deeper understanding of the complexities between HARFA and HIV 
reduction by further summarizing the scatter plot. For instance, Namibia received a 
modest amount of AIDS funding and had the highest rate change, or increase, in HIV 
prevalence. Uganda and Kenya had the lowest rate changes (indicating that these 
countries slowed the progression of the epidemic and reduce HIV prevalence at the 
surveyed sentinel sites), however Uganda received more funding for AIDS than 
Kenya. Burkina Faso, Cote d'Ivoire, the DRC and Nigeria obtain very little funding 
specific to HIV / AIDS, and yet these countries had some of the better percent 
decreases in HIV prevalence in the sample. 
5.1.2 HIVIAIDS relatedforeign assistance and ART coverage 
On the second indicator of HIV progress, my analysis aims to determine the impact of 
AIDS funding on access to treatment. An inspection of a scatter plot of log HARF A 
and log ART access in Figure 14 reveals a diagonal upward trend indicating a positive 
relationship between the variables. The bivariate analysis confirms this relationship. 
Pearson's r is positive and the probability of the association is high (r = 0.567)63. 
Since both variables are logged, we interpret the estimated slope measurement (b = 
0.44) to mean that a proportional change in HIV / AIDS related funding results in a 
proportional change in ART access. In other words, if a country was one percent 
above the average HARF A in the 29 country sample, it performed about .44 percent 
above the sample mean with respect to ART access. From this assessment, the 
empirical relationship between HARFA measured in 2003 and ART access is strong 
and significant. Across the 29 countries, HARF A statistically explains 30 percent of 
the variation in ART access.64 
The scatter plot provides additional contextual information. Botswana and Namibia 
are in the top right comer signifying high levels of AIDS funding and ART coverage; 
whereas DRC, Ghana, Madagascar and Nigeria at the bottom right comer, suggesting 
low funding and low access of treatment. Another observation includes the placement 
of Chad, which received the least amount of AIDS funding but provided moderate 
63 P < .001 
64 Adjusted R2 = 0.30 
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coverage "I' lICalmcm (! 7 p~rccm). SOUlh Africa is in the rniddk of the scmt~r plot 
representing an average for I-Iolh for~ign aid and treatment. 
Fi~" r<' 14: Scatter plot of Log HAIH.'" 2M3 .ml L<>g A KT Aeer" ~OO5 
,.-
" 0 
0 
" ,.-
, 
on _ 
'. 
• " '-" 
, ,. 
" 
" , ,. , ,. 
log HARF A PO ' c. p,,. 2OO~1~ 
R_."",,d_ •. " , -, 
rhe influence of additional fWlC.ling tlir~clCt.I m PEPFAR foclI.\ countries tloe, nol 
appear to improve ART covcrngc. While most of the countries in the lOp right corner 
arc PEPFAR focus countries, the other focus countries arc spread throughout lh~ 
scatler plot. For example, Tnnz8nia alll] Mozamhiquc arc ahovc the mctlian for 
HARFA howc\c,- lh~)' rank low On ART a<:~css_ To conlin11 that PFPFAR fimding: is 
not driving ART ",vcrag"_ 1 comillct a hi\'ariatc analysis of In g: HARF A and log ART 
a<;cess willi JUs( lh~ non-PFPFAR li><;us ~"untries and lind a positiv~ <lsst><;iution (r -
0.321 l.u-' From (hi s. We can ,oncl "de th<lt the addilional bi-l<Itcml forei gn <lid provided 
hy the PEPFAR progr<lm dlleS not purticul<!rly inf1uen~e ~ccess to ART tre<ltmcm 
a~ross the 29 <:ountri~s. 'Ionethciess. PEI'F A R funding is i nel uded in my definition of 
llARFA hecuuse it is hi-lateral aid; how~v~r it does nOln~ed sp~cin l oonsid~mtion in 
(he multiple regression analyses, 
Since l3ots\\ana pnwided the highest level of lreatment (S5 per~entl in 2(}()5 ~nd 
received th~ second highest amoum of HARFA in 2003, this case rC4uircs further 
" Thi, cmroiali"n i, a"'[Jally "ati,ticatty in,ignific"Il( (p - O.}}5) be<ouS!' ,ampl. size i, ;;!n ott. 16 
<nuntri« aro nnll _PErf" R, 
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contexllllilization. A large amount of private funding (which i~ 1101 inclcKled in my 
measlIJ'e of I L'\ Rf A), approximately I )S$ I O() million, \\ as in\~~ted ill Flolswana alier 
2()()() to launch a ma.>si\~ IreaUnent pmgramme in collaboration ",ilh lhe govemmem, 
the Gates Foundalion, lhe pharmaceutical companies (Merck and Bristol-Myers 
Squibb). and th~ llarvard AIDS Initiative {(jarrett, 2()()7), Even thOll~h problems 01" 
service delivery and ~t<lJl' ~horlages occurred, the fact remains that Rolsv,'an<1, 
compared to the other co llJlllie~. had the li,,( well funded treatment programm~, ,l11d 
this fact is reflected in th~ po~ition of'F\olswana on the scatter plot. 
5.1,3 Di.\C/I.\sivJ/ vIllle bil'lIr;(lle (lll(l(r.l'e,\' 
Thus. tv.'o important lindillg~ are drawn from the bivariate analyses oj IllV/,\IDS 
related foreign a~sislanc~ and HIY/AIDS progress, l'irst, there is nn cmrelation 
betv.'een IIARFA and lh~ ral~ nf change in HIY prevalence, Contrary to expe<:tation~, 
increased levds or AIDS JUllding do rlot appeartn reduce HIV prevalence (nor does it 
increase rates). 
Yet the Ol1lcom~ or lhis <malysis cOllld be a fUllctinn of the small sample of <:ases I 
was able lo use, III cmllltries It cOllld also be that the time span of the l\s<mlOi\h-Od~i 
et a1. stlldy (2004) i~ nOI long enough to measure the suc<:es~ of pn:vention 
progfill11m~S Dt:e Waal notes that it took eight years to show the fir~t si~n~ OrSl1CC~~S 
in Uganda, a country lhat bOOSIS "a success story"' (2()06. 1', 1(9), A more likdy 
explanation of t hi~ linding: is lhat lInlike treatment. HI V prevention relJllire~ behaviour 
change oj individuals within a pnplllalimL Since lhe relationship nf HA}{l i\ and J IN 
prevention validales the null hypothesis, Il llTll my attention to the second indicator of 
lllViAlDS pro~ress, ART access_ 
Ihe second main finding in thi~ '~clioll idelllil i ~s AIDS funding <1-, all impol'tam 
indicator of lrealment. Countries receiving more tL\Rl'A provide better covera~e of 
ART Yel even lhough lhe relatiollship between foreign nid ami treatment app<:nr~ 
slrong amI significant. theories discussed enrlier in the the~i~ ~ug~~sl Ihat all~maliv~ 
factors may influence J (IV/AIDS. If this is tru~, the n)bu~l ",lalionship b,:lween 
IIARfA and ART acc~% may be spurious and disapp~ar Or reduce once we consider 
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ot)}o.,r variables. These national chara~kri s\i ~s necd 10 he ~onsidcred as ,-lcl~nrlillaJl{s 
of acc~ss to tr~mmtllt as wdl as in!l utncts or A IDS rllnding_ 
5.2 The impurtanct' uf national cha r:H~ te ri s tics 
1 now nlOve to examin~ ilnd discuss the importanc~ of nalionill d1ilril~ttrisli~s_ Is the 
apparcntly strong rdationship ofllARfA illld a~~css to t!'tatmCIl1. as i dcnlill~d in lhe 
last section. illusive? Or does it rc!1ect the £ICI tlwt cffective illld wdl go\trncd S1ilttS 
do a octte!' job at com bating IIlV and simultancously tend 10 att ract illld r~~ciw bigh~r 
levels of i\\[)S funding? 'I hese are complicatcd qutstions thm require syst<'matic 
txploration. In th is scdion. 1 will lu.Jk sf""cifically at th~ relationships an",mg lh<' 
ind<:pemltnt vmi~hlcs. first. 1 want to detetmil~ if th~re is any pattern 10 Il">Rf A 
distribution and discuss which natiomll ~hara~teristics s~tm 10 attr<ICt fimdillg, I \\ill 
then assess other correlations among thc national characteristics, 10 identify 
associations. 1 usc a corrdmion matrix of the five va!'iabks (pr~s~nkd in rable 2) "": 
HIViAlDS related foreign assistancc. GOP per capita.. govcmancc. AlOS govemancc 
and sevcrity.OJ 
T ,hk 2: lIi,"riale Corre l.lion M.lri. of I ndepeIld.'n t V~ri.hl., 
Log Lo~ A II>S 
HAIU'A to UP 'r Cll ita GOn'rnann' GOn'rnaocc SCH'rit 
1.0' H,t, R FA , 
L"g_<i IlP _per capi ta .417: i , 
GOH'rnllnn' .J49" ~ ,424 ' , 
-~ ~ . ~ --- --- ~ . ~ ~ .. 
.". IOS GOHmann' _ I X 1 _ I 6 1 .437" , 
""',e,-il>' .612"" 2 S') - I '}() 0 /6 
• , , , I~- , .. 99'. confid<oce 
To address thc first 5<'t of q ucstions !'cgard ing funding illlocations. llARf A ~orrdatcs 
strongly wi th GOP per capita. go\'cm~nce and se\'~rity. which suggests that counties 
wi th more wealth. better go'ernanc~ and n)(l('c sevcrc cpilkmics ('c~ei\'c Hlore A10S 
ItLrld ing. In their sludy on aid cITecli\'cnCS8, FluITlside anJ Dollar lind lhat aid is 
"" A conohfian m"rri~ rr.,,,id<, 11>< bi" "im. eonehfinn , eu-efficiems befween e"ell ,'",i.bl., 
•• Becau," '"'orily is a dicl~'IO [OOU" me"",ro. I con i'>clud< if in, COnebf ion mmix, Tho E" from an 
Ano,," feSl ,Iw shows "inu"lly lb. ",m. conelorion b<lw •• n I TARF A "od ,;e •• rif), I 0,6 12)_ 
"p",l0 
" "M P ,v_' 
"' p<.OOI 
, U
niv
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e T
ow
n
a]io<:aleu to developing countries with bettcr institutional <.jl1ll1ily (21)04). M)' 
preliminary findings support this (hellr:y bec,"u~ more HARFA ~orr~'j1<md, with 
t>eller g"veman~~ and slate capacity. IlARFA abo correlates "jth se\'~rily_ Beller 
,\IDS govcmancc. however. docs not associate more foreign aid, 
To in,~slig ... 1C this further, I conduct a multiple regression whereby Ht\RFt\ is the 
dcr~ndenl ,ari"hl~ and (he three influ~ntial national characteristics arc independent 
v"riahl~,_ The rcsllilS w-e shown in Table J and identify >cverity as the strongest and 
111o>l signir;~anl driving raclor for HARFA distribution. which cOlllradicts the theory 
posed h" Bumsid~ and Dolhlr. Nonethd~ss, taken tog~ther, state capacity, governance 
und s~verity explain 40 r~r~~nt ofth~ varian~~ in foreign ,\IUS funding. 
Table 3, M" Hipl. ,"~re" i on r,>r Conlnlual Va.-iabk> "" HAKFA 
------------ 1-It>1!'>; 
B !kl~ 
Constant -.hS3 
Slale Ca :>cit\' .28 I 2()7 
(;overnance .127 _lid --
Sc>uily AS9 .51 ' " - -
N " Ad-u.</cd R- . .JI! 
• " •• " ~"confid,"c • 
Now Ihut I huv~ identjfi~d whut partly drives HARFA alloculions, I mlLsl also 
consider the other associations from rable 2, The nationul characteristics discussed in 
the literuture re"iew appear theoreticall" ~parale. however other hypotheses sllggest 
that the contextual variables relatc with one anoth~r, for ~xample. seyer~ epidemics 
may rcdllce state capacity and undercut dcmocrucy (:'vlaltes, 2003); d~ll1ocratic 
governance may promote idealistic AIUS governance hy improving hum'-Ill rights and 
other lih<-'Tties (lisu. 2005): and state capacity may improve governance, and vice 
\'cr:sa. Ihmugh go\'ernll1~nl rea~h "'ld drc~liven~ssJl In ra~L lhe bivariale ~"rrdalions 
in Table 2 show that governance correlates strongly with state capacity and AIDS 
gowmance_ This indicates thaI COllntri~s with better goveman~e gen~rally ha\e 
' I llo" 0, cr, r""oarth ha, "ho"" lhal io A [rica, Iho rclalill",hip b,1" oC" _,u"o <apacily "nJ ~o,w",,,,,~ 
hd' n""CT bc~" '1T(>Il~ doc II} colon;"1 hi'IOr)', ~conomi, <ri,~" ,lou politiuLI i"qahilit)' (BTliullgdm & 
Kndt'k_ 20(4) 
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greater wealth and higher levels of idealism in AIDS governance. The severity of the 
epidemic, however, does not appear to adversely affect state capacity or democracy. 
These are interesting findings that reqmre further exploration; however for the 
purposes of this section, I only recognize the empirical relationships, or endogeneity, 
among the five independent variables. Through this analysis, it appears that the 
relationship between HARF A and treatment is not spurious. The severity of the 
epidemic appears to drive donor funding, and it is unlikely that countries with higher 
levels of HIV prevalence can provide increased treatment independently of foreign aid 
because these states have a greater demand for treatment. 
Yet the theories discussed earlier propose that national characteristics may influence 
HIV/AIDS progress. Even though more wealthy and better governed (both generally 
and specific to the epidemic) states do not appear to attract more AIDS funding, these 
same states may do a better job at combating the epidemic. Therefore, I must first 
look at the relationships between the national characteristics and ART access before 
suggesting that foreign aid for HIV I AIDS is the most important determinant of 
treatment. 
5.3 The impact of national characteristics on treatment 
The four factors identified in the literature review (state capacity, governance, AIDS 
governance and severity) posit that different national characteristics may be linked 
with HIV I AIDS progress. The theory behind this hypothesis suggests that the 
effectiveness of institution and bureaucratic processes as well as idealistic AIDS 
responses determine the rollout of treatment. This model considers these contextual 
variables as the independent variable and ART access as the dependent variable. I use 
scatter plots and bivariate correlations to assess the relationships. 
5.3.1 State Capacity 
To recall the argument about the impact of state capacity on HIV/AIDS in Africa, de 
Waal (2003) and Poku (2006) argue that African states generally lack the resource 
capabilities (i.e. weak infrastructure and health service delivery) to combat effectively 
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the epidemic. Price-Smith et al. (2004) find that countries with more general wealth, 
as well as better access to doctors, education, telephones and infrastructure, 
experience greater progress in the fight against the disease. If the logic and evidence 
underlying Price-Smith's study of state capacity is correct, I would expect to find a 
positive relationship between state capacity and ART access signifying that countries 
with better state capacity (i.e. more wealth) provide more ART access.72 
The scatter plot of log ART access and log GDP per capita in Figure 15 supports this 
hypothesis with a positive slope. It appears that wealthier countries do indeed tend to 
provide greater ART coverage to people who need it. This is confirmed by a strong 
and significant bivariate correlation (r = 0.442).73 Since both variables are logged, we 
interpret proportional changes. The estimated slope measurement (b = 0.47) indicates 
that a country with one percent above the average GDP per capita of all countries was 
also 0.47 percent above the average with respect to ART access. The relationship also 
appears partially linear and explains 20 percent of the variation in the dependent 
variable. 
As the hypothesis predicts, it appears that greater state capacity Improves the 
effectiveness of the response to HIV/AIDS, in terms of treatment. It is therefore 
expected that countries with higher levels of state capacity will provide the uppermost 
levels of ART access. Botswana and Namibia illustrate this relationship perfectly as 
representing the second and third wealthiest countries and doing the best in ART 
provision. Likewise, the DRC and Madagascar have some of the fewest resources and 
hence provide the lowest coverage of treatment. 
72 The measurements for the included variables take into account population size. ART access is 
measured as a percentage of HIV -positive people receiving treatment who need it and the state capacity 
is measured by per capita. 
73 p <.05 
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The c,,~~ of Soulh J\lricil requires some attcntion a~ il l~ an nUlli<'-"r ilIld should be 
dning a much n.oller job at providing lreatmcnL It has lhe high~sl level uf Slale 
capacily in Ihis silmpl" but ranks l1ear thc middle of Ihe silmpk fur providing 
tr~almer1l witb only 21 pcr~ent of AR.T acccs, for pcopk \\'hnl1~ed it. SUUlh Afrka is 
a unique Ca';e IXCiIUS~ il lild s unily in lbe fighl again;;1 HIViJ\IDS. Th~ discuursc of 
AIDS dCIlialism ) ~ ill the ftll'eITunl of Ihis problem "hcrcby lhe govemmenl. civil 
society, scientists ilnd ac,td~mi cs disilgree un the best melhod~ 10 combal HIViAIDS 
(Nallra~s, 20(7). 
5,1,2 U()!'CmllllCl' 
To recall the litcrature about g<l\~miln~t ilnd lJlV./AlDS progress. H~u (2005). D 
Pattcrson (2001) altd ulhers argue lhat "good govemance" i~ an dTeclive way to 
colllrol HIV/AIDS. Thi;; ilssumpliun is based upon the lhcory that nalinnal Slilbility. 
clTeclive 11;llioIlill pulicks and improved political. civil and humill1 rights provide a 
secure environmcnl conduci\"~ 10 ~umbating Ihc epidemic. Case studie, h,,,~ ~hn,,'T1 
that w;coumability, lransparency, pilrlicipilliuJl ilnd a~<:ess to information reduce HIV 
iJlcidtIlc~ and in~rcase treatment (two examplc~ ilT~ Thailand ill1d Bmzil) (Tlsu, 2005). 
D1I<' lu Ihe lbeory and case studics. I expecl lhat bel1~r guvemed Ali-ican coul1 trics 
have grrater Ie' t Is of 1C<:<Juncnt. 
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The ~cauer plO! in rigun: 16 supports th~ hypothesis of good governance rdating to 
HIV/AlDS with a positive ~Iope. Thi~ is eonlinn~d hy ,I slrong an.I signilicant 
hi variate ~orrelation (r - 0.S8 1)." To un,krst;llld lh~ slope lUeasurt'mt'nt (b-0.316) 
consiJer (hat for ever) ~tandard deviation in~rcase (or dccreast') on the World Bank 
gowmanee scale, ,I country experiences a 0.32 jncrt'ase (or decrt"lse) ill lh~ 
proportional perc"ntagt' ch,mgt' 111 ART acct'ss. G"neral gll\'t'manct' is ,Ill inilueillial 
t~ctor hecause it explains 27 ]J<'rct'1l1 of tht' variation in ART access. 
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The cmpirical findings seem to support th~ hypoth"sis Ih,lt better govt'ITIt'd couillries 
provide grcater ART covcral,':c, llolswana and Namihia al,':ain dcmonstratc this 
relationship because thC} l'eprcscnt thc cOllntrics with (hc highcs( levels of govcrnance 
aIlJ prnviJe the most treatment; in contm~t IOC ORC represents lhe cOlliltry with the 
lowest levels of govcm"nce and ART access. Th~ re~( of toc sample falls betwcen 
lhe~e Iwo exlreme, on a relalive l) inclining anJ parliall) linear pauem. However, 
de~pite the ~latistical eviJence pres..;nted "hove. lhe (hree countries afl~r 'Jamihia on 
the governance seale deviak Jms(icall) from the panem South Africa proviocs 21 
perc-cnt acc-css to ART, anJ \1aJagascar and Ghana only supply 6-7 perccnt treatment 
coverage, This is far less than cxpeeted whcn considering thc theorics presented by 
I lsu (2005) and D, Pmtt'rsoll (2001). 
" p<,Ol 
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5.3.3 AIDS Governance 
The AIDS Program Effort Index (API), which measures AIDS governance for this 
study, was designed by international AIDS institutions and donor agencies to assess 
national efforts in the fight against the disease. There is an assumption that more 
political support and certain policy developments lead to more effective responses. 
These organizations encourage a human-rights based approach, or more idealistic 
AIDS governance, because they assume it will positively affect HIV/ AIDS progress. 
Based on their criteria, I expect that countries with higher levels of idealism in AIDS 
governance, or higher API scores, provide greater ART coverage. 
In Figure 17, the scatter plot of AIDS governance and ART access indicates a positive 
slope and therefore supports this hypothesis. This relationship is validated with a 
strong bivariate correlation (r = 0.422).75 The estimated slope (b = 0.013) means that 
for every point increase on the API scale, countries experience about 0.01 percent 
increase on the logarithm scale of ARV access. AIDS governance explains 18 percent 
of the variance in treatment. 
The empirical results support the logic that countries with higher levels of idealism in 
AIDS governance have greater ART coverage. The relationship does not appear as 
strong as the previous national characteristics and this is confirmed by observing the 
location of countries on the scatter plot. For example, Botswana and Namibia no 
longer perfectly represent the relationship as they did with state capacity and 
governance. Botswana remains high on the API scale and high on treatment access; 
however, Namibia only ranks tenth highest in the sample of API scores. Senegal, 
Rwanda and Uganda provide relatively high levels of treatment and also have higher 
levels of idealism in their AIDS response. Lesotho has the lowest API score in this 
sample (39) suggesting that it has low levels of idealism, yet it does not provide the 
least amount of treatment. Likewise Burkina Faso has the highest AlP score (82) but 
does not provide the most coverage of ART. These two examples demonstrate the 
ambiguity of the relationship between AIDS governance and treatment. 
75 P <0.05 
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It is important \0 note how"vcr that the API inciuJcs 1\\0 questions about treatmen!. 
R"'p0ndenls WCre asked to rank ,.::sources available for treatment as well as to 
identity ifil was pari orlhe n~lional programn..:: for HI\,'iA1DS (I ;SAlD ct aI., 2()03. 
p_ 33&44). How,,;'cr, ART prOVISIOn was One option amongst 17 other health 
provisions (su~h as orphan Care and mother \0 chilJ programmes) within each 
question. The report recognizes that "the index is intcnJed to measure pl'Ogram effort 
indepclllkm of program outputs" "hereby policy and political prioritization arc 
indicators opposed to tHY progress in actual tenns. such as the AR'J coverage 
(lJSAID el ai. , 2()03, p. I). Therefore, 'We can use the API when assessing the impact 
of AIDS gOl'ernance on ARr oovemge. 
5.3.4 Se,wity 
Barnett and Whiteside (2()05) recognize that tlifferent societies experience diffCl'ent 
types "ntl !lows or the epiderllic. The severi ty variable atterllpts to measure the extent 
or tlK'" epitlemic by indicating whether a cOlLntry has experienced high (over 10 
]X'"l'cen\) or low (below 10 percent) HIV pl'ev~lence levels since lC;<)7. It is IInclc~r 
"hdher ART ~cc~ss is simply ~ function o l ' th ~ aclual llced ror treutment rather thall 
the COlltext or the country. Perhaps COUlltriCS wi th severc epidemics provide grcaler 
access to treatment occause the exlent of HIViAIDS is recognized and prioriti/.e by 
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national leaders and dOllors as a major problem, Altemati\'ely, thcsc countries have a 
greatcr dcmand for treatmen\, which may limit ART coverage, I therefore I\am to 
dcterminc if the sevcrity of the H I V JAJl)S cpidcluic affects acc~ss to tr~atTllenL To do 
this, I run a difference of mcans test, which allows me to comparc thc means or 
(rcatmem access fol' cOlUltries elassified as severe and mild. For imapreta(iollal 
purposcs, I use raw AR I' access data and not the logged data. 
rall!< 4: ()iffcrcnot' ,,1' lIlt'a", f",- ART ,,,'CO" and ,e,'c,-i (,' 
Mild 
,'.) " : IU" 
bbk 4 shows the r~sul!s oftl-.e n)Can ~oTllpariS(JTl l>e\,,~~n countries with s~\'er~ Or 
mild "pid~mics. ClllLlll ries dJssilied as expe nellC1l1g severe epidemics JCWIllly 
pro\'ide greJ\er lreatment coverage "'i\h 27.57 percenl l\RT access opposed 10 
~oul1lries with mild epi d~1l\i ~s that only provide 20,33 percent coverage"" These 
results support the first bypothesis thallbere is greJter access to treatment in Clluntries 
with sner~ ~pid~m i cs. 
III lhis XC IlOn, I hllve empirically demonS/raled thJtmtional chllrJcteristics do appeJr 
to influcnce treatment mlxlemlely, Spo;cificlllIy. GOP per capita, go\cmance and 
/\IDS goverrull1ce sUll1d out JS hllving stalistically significmll assll·cimions to AR I 
access, whicb supporls lhe tbeoretiCli1 Ilrguments IllJde in (he lilemture review, 
Howe,er, ll-.ese lindings require further explorJtion. especiJlIy considering the 
previous results on thc link of stille chara<.1:eristics and AIDS funding. rhe ncxt 
section will Cllntinlle to investigate thcse relationships whilst CDmrolling for lIARL\. 
5.4 IlAHFA and national characteristics in a multiple regression 
Before W~ pro~~~d any furlhu, 11 is useful to pause Jlld review the lindings thus lilr. 
First, lrn.'rl' is a slronj.\ asso<:ia[iOTl bet"'~~n A IDS I'undinj.\ ,md a~cess 10 lr~alm~nL 
Second, foreign aid for HIVIAlDS control apl)Cars to he dishursed primari ly to 
countrics based Oll the sevcrity of the cpidcluic; lxJwe\er foreign aid is also linhd 
with GOP Ixr capita lind gll\'Cmance. In Jddition. there arc observable statistical 
" !'oil lhe din","n,," "[m"a,,, Ie", the e la is m",k,al" OUl n,,' signific.nt \EU, - I ~~, F-stmi,tic -
.W3). Th" in,ign ilk.""e ,,1' lhi. T",u ll i. mml likel} doc to tl'" , m, II ","'pic , i7e ""d tho .~IT.m . '""., 
"j,h i" the "'",plo ,och "-, f)""",,",. 
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associations between some of the other national characteristics (GDP per capita, 
governance and AIDS governance) and HARF A. Finally, national characteristics 
partly influence access to treatment, which may affect the original relationship 
between donor assistance and treatment. 
I must therefore determine if HARF A is still linked to ART access even after 
controlling for these other influential variables. If HARF A retains a strong and 
significant effect, then donor assistance matters for treatment; however if the 
relationship disappears or declines, then access to treatment may not depend on 
foreign aid, which would have important policy implications for donors, national 
leaders and other actors. I use a multiple regression analysis to empirically assess the 
influence of HARF A on treatment. 
The results from a multiple regression indicate that HARF A is the most influential 
factor explaining ART access. To determine this, I consider the findings from four 
models shown in Table 5. The first model reports the results from a linear regression 
of HARF A on ART access. Even though these figures were recorded in section 5. J. 2, 
they provide a basis from which to compare the effects of the other variables on 
HARF A's relationship with ART coverage. In addition to having a strong and 
significant correlation coefficient, the regression analysis shows that AIDS funding 
explains 30 percent of the variance in treatment. This is more variance explained than 
any of the national characteristic. 
In the prevIous section, I individually tested the influence of the national 
characteristics on ART access and found that there is a modest and statistically 
significant impact of state capacity, governance and AIDS governance on treatment. I 
now want to include the four variables in a multiple regression to determine if these 
associations remain strong even when controlling for the other national 
characteristics. Model 2 shows the results from this regression analysis and indicates 
that the individually robust relationships, reported in section 5.3, are muted when 
taking into account other national characteristics. All four associations reduce in 
strength and significance. This is most likely due to the endogeneity among these 
variables because governance, GDP per capita and AIDS governance conceptually 
and empirically overlap. 
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T ah l. 5: ,\] uti i1'10 r.~r<"i[)n f[)r II A RFA and Conlt,lual Vori.blt> Oil It RV acct" 
I add HARFA to this multiple regn:ssion analysis to "ss~ss its effe~t on the modd 
because IIARj·A also correlates with some of thc nation,,1 characteristics (as 
discussed in scction 5.2). r.lodel3 records the rcsults of this analysis. which includes 
IIARFA and the four nation"l ch,mlCteristi~s as the independent variables. While the 
impact of the national ch,lJ·acteristics on treatment reduces even further, the 
correlation coenicicnt for HARfA rcm~ins strong ~nd signilic;mt even after taking 
into account thc levels of wealth, governance and cpidemic (although the standardized 
eod"fickm docs dccrease to 0.5(6). from this mudd. it "ppears th"t donor ~ssist~nce 
dircctly influences treatment. 
Nevertheless, the theory behind the four national characteristics inlluencing 
IlIV/AIDS progress is too convincing to discard. To prevent the endogeneity problem 
among the independent variables from leading us to prematurely thro" out this 
explanation, I include the most influential national characteristic in a multiple 
regression "ith I1ARFA. To detenuine "hieh yariahle has lhe mo,t influence, I drop 
fac;toTh out ofthc multiple regression ,)ne b} one based on "hieh factor has the 10\\lest 
prohahl} (or highest "p'.). Stale capacity is the lir~t yariable remuved. lhen ,,,,,->fily 
and !inally AIDS goyeman~e. Therefor" or the four national ~harac;ten~llC' ~eleded 
for lhi~ ~llLd}. gmemanee is empirically the most influential factor for ART co\"cragc. 
Statistically. this is supportcd occausc governance has the highest and most significant 
bivariate association with treatment (r ~ 0.581). In addition. the theorctically 
argument \>ehind its impad on HIV /AlDS progress has been develuJlCd e~lensi\"ely hy 
international in,titulions a~ well as independent a~ademi~s. 
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Model 4 reports the results from a multiple regressIOn analysis of HARF A and 
governance on treatment. 77 Both variables remain statically significant however the 
standardized correlation coefficient for governance reduces more than the coefficient 
for AIDS funding. By adding the governance variable to the first model, the variance 
explained increased nearly 10 percent from the first model. Therefore, HARF A and 
governance together explain 39 percent of the variance in ART coverage. This 
empirically demonstrates that treatment for AIDS is determined in part by HARF A 
and by high levels of governance. 
The empirical evidence suggests that there is a strong, positive and direct impact of 
HARFA on HIV/AIDS progress as measured by ART access. This outcome implies 
that AIDS funding appears to help Sub-Saharan African countries dispense ART 
regardless of state wealth or the severity of the epidemic. Governance also directly 
influences treatment signifying that better governed states are providing more 
coverage of treatment regardless of their situations; nevertheless, in empirical terms, 
HARF A has greater influence on treatment than governance. 
These findings in part support the theoretical assumptions discussed in the aid 
effectiveness literature review. The fact that HARF A goes to countries with higher 
levels of HIV prevalence partly confirms that foreign aid is most likely to go to states 
that need it (Burnside and Dollar, 2004; Sachs, 2005b). Yet better governed countries 
are doing a better job at combating the epidemic, which indicates that good 
governance also matters for HIV I AIDS progress. 
Thus far the results indicate that HARF A is an important component of treatment, and 
that it is effective regardless of the recipient state's characteristics. Before we can 
finally confirm this statement, we need to check whether AIDS funding has different 
levels of impact depending on the national characteristics of these African countries. 
The question now becomes, do national characteristics moderate the linkage of 
HARFA and ART access? 
77 I also conducted a multiple regression ofHARFA and the other individual state factors on ART 
access. Governance has greater significant and associations than the other variables. AIDS governance 
remains significant but does not affect the impact of HARF A on treatment; state capacity and severity 
lack statistical significance. 
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5.5 National characteristics and HARFA on ART access: an 
interaction analysis 
The previous section provides empirical results that foreign aid for HIV / AIDS directly 
effects ART access. In this section, I want to determine if national characteristics 
modify the impact of AIDS funding. In other words, is there a greater "return to 
HARF A" in better governed states or in states with greater wealth? Or is the impact of 
HARF A constant across states? Evidence from the Burnside and Dollar study on 
foreign aid accelerating economic growth indicates that the impact of aid depends on 
the quality of state institutions and policies (2004).78 Based on their work, I have 
theoretical grounds to look at the impact of national characteristics on the relationship 
between HARF A and ART coverage. Does the quality of state institutions, the 
capacity to absorb funds, AIDS policy and severity of the epidemic modify the 
effectiveness of HARF A? 
In order to examine this question I analyze the interaction effect of HARF A and 
national characteristics on ART access. Basically, the interaction effect measures how 
much one factor (z) influences the relationship between two other factors (x and y). If 
factor z has great influence on the linkage of x and y, the relationship is dependent on 
factor z. If there is no influence, factor z does not matter. In statistical terms, the most 
commonly practiced method of determining the interaction effect assesses a multiple 
regression with the independent variable, the moderator variable and the interaction 
variable (measured by multiplying the independent and moderator variables) on the 
dependent variable. 79 The equation is: 
y = a + b/(x/) + b2(X2) + b3(x/ X2) 
The results from this analysis consider the value of the interaction variable in a 
multiple regression. If b3 differs significantly from zero, the interaction is significant, 
and we can say that the moderator variable affects the relationship between the other 
variables. However, if the interaction variable is weak or close to zero, it suggests that 
it does not influence the relationship. 
78 Burnside and Dollar recognize that there is no support for the competing hypothesis that aid has the 
same positive affects everywhere (2004). 
79 This model is described fully in Allison (1977) as well as Jaccard and Turrisi (2003). 
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I calculated the interaction effect of all four national characteristics on the impact of 
HARF A on ART access and found that none of the interaction tenns are statistically 
significant. However, the transfonnation of the variables to logarithms and the small 
sample size may limit my capacity to empirically detennine the interaction effect. 80 
Thus, I assess the possible impact of the national characteristics on the link between 
HARF A and ART access by using dummy variables to test for variation in the 
national characteristics. To do this I use the mean of the variable measurements to 
dichotomize the national characteristics variables (please see Appendix F) and assign 
countries as high state capacity or low state capacity; good governance or poor 
governance; higher levels of idealism in AIDS governance or lower levels of idealism 
in AIDS governance; severe or mild epidemics. Once I separate the variables, I run a 
linear regression between HARFA and ART access with both sets of categories and 
compare results. If the intercept and slope coefficients differ (taking into account their 
confidence intervals), than the national characteristic influences the effectiveness of 
HARFA. 
Based on the hypotheses of this study, I expect that the effectiveness of HARF A on 
ART access will be greater in countries with high levels of state capacity, better 
governance, more idealism in AIDS governance and mild epidemics. The results from 
the comparison regressions are provided in Table 6. For state capacity, the intercept 
and slope coefficients differ very slightly suggesting that countries with high state 
capacity experience greater effectiveness of HARF A. The level of governance does 
not seem to moderate the relationship between HARF A and ART access because the 
regressions are similar. For AIDS governance, the intercept and slope coefficients of 
the two regressions also differ slightly. Countries with less idealism in AIDS 
governance have a lower intercept point and slope than countries with more idealism 
in AIDS governance, which seems to indicate that HARF A is more effective in 
countries with more idealism in AIDS governance. For severity, the intercept and 
slope coefficients reflect that the severity of the epidemic does not drastically change 
the impact of HARF A on ART access. 
80 Allison argues that interaction cannot be estimated with logarithmic measures (1977, p. 151). 
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HO\,e'~r, while these lindings appear re,,,al ing and significant, Ih"y ar~ in Iil.ct not 
The ino:;luslon of the 95 percenl confidence inter\'al demonslrates that there is 
considerable o\erlap OCnlss all I(,UT national charOCleristic comparisons. If governance 
or ·weallh delem,ined the elTecliveness of HARFA, then the inter\'al between the 
low"r and upp"r confidenc~ points wnLlld ill,t ov~rlap as th"y do. I"h",..,fnr", the large 
confideno:;e inter\'al of OLlT regress ion coelTicienls illustrates that the ""re turn to 
HARFA·' does not dill'-.,. signil icanlly bel\~ee n low and hlgh categories of each 
natJOwl ch~rJcteri,tic. This rejeCls the hypothesis that the impact of foreign aid on 
tre~tment is moderated by the chanlClerisli~-, of the reClpiem cOLlntry. Un
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CHAPTER SIX 
CONCLUSION 
Does HIV/AIDS related foreign aid really work for HIV prevention and treatment? 
This is a complex question and cannot be answered with a simple yes or no. The 
academic journal Foreign Affairs published a special edition on global health in 
January 2007 providing space for academics to debate the current challenges of global 
health ("How to promote," 2007). At the forefront of this debate was HIV/AIDS; at 
the core was foreign aid effectiveness. While no one denies that more aid is needed to 
combat HIV I AIDS and other diseases in developing countries, scholars disagree over 
how AIDS funding should be dispersed and how to assist weak health systems. 
However, if we want to convince donor and recipient countries "to maintain the AIDS 
response as a priority" (Piot, 2006: 527), we need to provide evidence that AIDS 
funding does indeed "work" (de Waal, 2007). This thesis is an attempt to do that. 
6.1 Summary of Findings 
The quantitative method chosen for this study provides empirical evidence that 
HARF A does work for AIDS treatment but fails to locate similar evidence for HIV 
prevention. How seriously can we take these results? Using the best available data, I 
determined the associations by employing three statistical analyses and taking into 
account statistical significance and standard error. In addition, I considered time order 
and controlled for third variables to cancel out potential spurious relationships. 
Finally, and most importantly, I used theory to drive this research. While this thesis 
does not go into all of the intricacies of HARF A effectiveness, I have established the 
general causal claim that more HARFA yields greater ART access. Even though this 
seems to be an obvious conclusion, it is one that until now has not been empirically 
proven. This study provides evidence that there is a direct association between AIDS 
funding and treatment whereby countries receiving more HARFA have better ART 
coverage and that it is not simply due to better ability to absorb or spend foreign aid. 
A second major finding is that the "return to HARF A" is constant across countries 
regardless of the levels of state capacity, governance, idealism in AIDS governance 
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and the severity of the epidemic. In other words, HARF A is similarly effective in 
countries with high or low state capacity, good or poor governance, high or low levels 
of idealism in AIDS governance, and mild or severe epidemics. Does this study 
therefore argue that donors can confidently give AIDS funding to countries regardless 
of their institutions, policies, epidemics, and capacity? It would be irresponsible to 
make this claim without further research. My measurement of HARF A is broad and 
does capture the complexities of the donor agencies and recipient organizations nor 
does it distinguish between the type of aid and the potential conditionality of aid. It 
also does not consider how aid is dispersed i.e. salaries, medicine, infrastructure, 
etc .... More research and investigation is needed before these results can become 
conclusive. 
The final finding of this thesis reveals that HARF A does not influence the change rate 
in HIV prevalence. I have already discussed the limitations and challenges of using 
HIV prevalence data to monitor HIV/AIDS progress (chapter 3.6) and attempted to 
control for these limitations by using a trend series study of the same antenatal clinics 
over a period of six years. Yet, this drastically reduced the sample size to 16 countries 
and created further limitations.sl To my knowledge, I used the best data available to 
measure HIV prevention and it still did not show results. There are many factors that 
can influence HIV reduction, therefore more investigation and data collection IS 
needed before we can claim that HARF A does not impact HIV prevention. 
6.2 Implications and Future Research 
This analysis provides empirical evidence "that the major investments made in 
fighting AIDS are having a commensurate effect in terms of averted infections, 
illness, and deaths" (Piot, 2006: 527). From this study, we know that HARF A works 
for ART coverage. Therefore, donors should be encouraged to continue financing 
AIDS treatment programmes. The failure of the WHO's "3 by 5" campaign,82 
designed to bring ART to three million people by 2005, may have caused 
81 The figures for each country are not representative of all antenatal clinics within that country. They 
are only taken from participating clinics which varied among countries (some countries had 5 clinics 
whereas other countries had 66 clinics) (Asamoah-Odei, 2004). 
82 WHO and UNAIDS (2006) estimates that more than 1.3 million people were receiving treatment by 
December 2005. 
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disappointment and doubt in the international community, aid agencies and recipient 
countries. Yet, just because the target goals were not met does not mean that the aid 
did not work. The failure overshadows the fact that more HIV -positive people are on 
treatment because of an increase in HARF A. As Fanner remarks: 
In 2002, there were almost no antiretroviral (ARY) medications in rural Africa, nor were 
there personnel to deliver them. In 2007, most African nations are working to make 
AIDS diagnosis and care "a public good for public health" ~ that is, a service paid for 
by the commonwealth or rich donors, rather than by individual AIDS sufferers and their 
families. Although these drugs are as yet reaching very few rural Africans, the past five 
years have seen significant investments, at the district if not the village level, to make 
AIDS therapy available for those who are able to walk or find other transportation to 
district hospitals. (2007) 
In regards to the effectiveness of aid on treatment, the four national characteristics 
included in this study as moderator variables did not have an impact on the link 
between HARF A and ART access. Additional research is required before policy 
implications can be established. The results from this thesis provide grounds for 
further investigation because it detennines that donors disburse more funding to 
countries with severe epidemics, and yet severity does not mitigate the effectiveness 
of HARF A. There are other possible factors to consider and control for in future 
research such as colonial history, current trade and economic policies. In addition, the 
expansion of this study to include other regions of the world would allow for 
interesting comparative research. A larger sample size of more diverse countries may 
also produce different results and find that the moderator variables do in fact impact 
HARF A effectiveness. 
The last point I will address concerns data limitations. In order to monitor and 
evaluate the progress of the HIV / AIDS epidemic, better indicators must be 
established. UNGASS reports country level bi-annual progress of the disease and 
indictors (i.e. the number of people educated in HIV / AIDS, condom use and HIV 
prevalence). However, their reporting system is f1awed; data is often missing; and 
reports are non-comparable because of methodological differences. This study 
demonstrates the limitation of using currently available data. For their next bi-annual 
report, UNAIDS has developed better output indicators as well as indicators 
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measuring HIV/AIDS resource activities.s3 Let us hope that future research will be 
enriched by this new data and will be used to further investigate HARF A 
effectiveness. 
This thesis looks at the overall impact of AIDS funding in Africa. In part, it considers 
the big picture because it explores macro-level data. The broad approach prevented 
this study from dissecting where aid goes, who receives it and how it is spent. Now 
that there is evidence to suggest that HARF A works for treatment, and more detailed 
information on HIV I AIDS spending will be available in the near future, further 
research is necessary to determine if AIDS funding is as effective as it could be. It is 
hoped that the evidence presented in this research will encourage increased discussion 
and debate and enlighten future research. 
83 The National AIDS Spending Assessment (NASA) measures the actual expenditures for HIY/AIDS 
in terms of domestic, international and private resources (T. Guthrie, personal communication, March 
23,2007). 
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Appendix I); Governance Index and I)ata 
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Table 14: Governance 2003 Correlation Matrix 
Voice Political 
and Acct. Stability 
Voice and 
Acct. 
Political 
Stability 
Government 
effectiveness 
Regulatory 
quality 
Rule of Law 
Control for 
Corruption 
o 90% confidence 
N =29 
1 
.758** 1 
.735** .707** 
.737** .680** 
.846** .834** 
.750** .745** 
* 95% confidence 
Government Regulatory 
effectiveness quality 
1 
.819** I 
.852** .842** 
.760** .773** 
** 99% confidence 
Rule of Control for 
Law Corruption 
1 
.899** I 
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Appendix E: International Country Codes 
Table 15: International Country Codes 
Country Country code 
Angola AO 
Benin BJ 
Botswana BW 
Burk Faso BF 
Burundi BI 
Cameroon CM 
Chad TO 
Congo CG 
Congo DR CD 
Cote d'Ivoire CI 
Ethiopia ET 
Ghana GH 
Kenya KE 
Lesotho LS 
Madagascar MG 
Malawi MW 
Mali ML 
Mozambique MZ 
Namibia NA 
Nigeria NG 
Rwanda RW 
South Africa ZA 
Senegal SN 
Swaziland SZ 
Tanzania TZ 
Togo TG 
Uganda UG 
Zambia ZM 
Zimbabwe ZW 
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Appendix F: Dichotomizing variables 
An explanation of the methodology used to dichotomize the contextual variables will 
be provided in this appendix. The classification of the contextual variables will be as 
follows: high state capacity or low state capacity, good governance or poor 
governance, and more idealism in AIDS governance or less idealism in AIDS 
governance. I use data from 2003 because I assess HARF A at this time point. In order 
to dichotomize the variables, I use the mean of the sample. Countries above the mean 
of the logged measurement of state capacity (3.18) are considered countries with high 
state capacity; whereas countries below the mean are categorized as low state 
capacity. The governance variable is measured on an interval scale from -2.5 to 2.5, 
however this sample only falls between -1.88 to .78. I will use the mean of the sample 
(-0.6) to assign "good governance" for countries above the mean and "poor 
governance" if below the median. For the AIDS governance variable, countries with a 
score below the mean (64 percent) will be considered to have less idealism in AIDS 
governance where as countries above the median will have more idealism. 
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